1 2 3 4 5 6 7 8 9 10<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" 11 "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> 12<html xmlns="http://www.w3.org/1999/xhtml" lang="ru" 13 prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# profile: http://ogp.me/ns/profile# fb: http://ogp.me/ns/fb#" > 14<head> 15 <meta name="viewport" content="width=device-width, height=device-height, initial-scale=1.0, user-scalable=1, minimum-scale=1.0, maximum-scale=4.0"> 16 <meta http-equiv="Content-Type" content="text/html; charset=utf-8" /> 17 18 <title>ÐÑÑекÑивноÑÑÑ Ð¸ безопаÑноÑÑÑ ÑиÑзепаÑида в леÑении ожиÑÐµÐ½Ð¸Ñ Ð¸ аÑÑоÑииÑованнÑÑ Ñ Ð½Ð¸Ð¼ комоÑбиднÑÑ ÑоÑÑоÑний | Ð¡Ð°Ñ Ð½Ð¾Ð²Ð° | ÐедиÑинÑкий СовеÑ</title> 19 <meta name="title" xml:lang="en" lang="en" content="Efficacy and safety of tirzepatide in the treatment of obesity and obesity-associated comorbidities"/> 20 <meta name="description" xml:lang="en" lang="en" content="Efficacy and safety of tirzepatide in the treatment of obesity and obesity-associated comorbidities | Sakhnova | Meditsinskiy sovet = Medical Council" /> 21 <meta name="title" xml:lang="ru" lang="ru" content="ÐÑÑекÑивноÑÑÑ Ð¸ безопаÑноÑÑÑ ÑиÑзепаÑида в леÑении ожиÑÐµÐ½Ð¸Ñ Ð¸ аÑÑоÑииÑованнÑÑ Ñ Ð½Ð¸Ð¼ комоÑбиднÑÑ ÑоÑÑоÑний"/> 22 <meta name="description" xml:lang="ru" lang="ru" content="ÐÑÑекÑивноÑÑÑ Ð¸ безопаÑноÑÑÑ ÑиÑзепаÑида в леÑении ожиÑÐµÐ½Ð¸Ñ Ð¸ аÑÑоÑииÑованнÑÑ Ñ Ð½Ð¸Ð¼ комоÑбиднÑÑ ÑоÑÑоÑний | Ð¡Ð°Ñ Ð½Ð¾Ð²Ð° | ÐедиÑинÑкий СовеÑ" /> 23 <meta property="og:title" content="ÐÑÑекÑивноÑÑÑ Ð¸ безопаÑноÑÑÑ ÑиÑзепаÑида в леÑении ожиÑÐµÐ½Ð¸Ñ Ð¸ аÑÑоÑииÑованнÑÑ Ñ Ð½Ð¸Ð¼ комоÑбиднÑÑ ÑоÑÑоÑний | Ð¡Ð°Ñ Ð½Ð¾Ð²Ð° | ÐедиÑинÑкий СовеÑ" /> 24 <meta property="og:type" content="article" /> 25 <meta property="article:author" content="Ð. Ð. Ð¡Ð°Ñ Ð½Ð¾Ð²Ð°"> 26 <meta property="article:author" content="Ð. Ð. ÐавÑилова"> 27 <meta property="article:author" content="Ð. Ð. ÐÑÑÑоÑмова"> 28 <meta property="article:author" content="Ð. Ð. ÐоÑеÑков"> 29 <meta property="article:author" content="С. С. Телкова"> 30 <meta property="article:author" content="Ю. С. ÐоÑÑкова"> 31 <meta property="article:tag" content="ожиÑение"> 32 <meta property="article:tag" content="аÑÑеÑиалÑÐ½Ð°Ñ Ð³Ð¸Ð¿ÐµÑÑензиÑ"> 33 <meta property="article:tag" content="диÑлипидемиÑ"> 34 <meta property="article:tag" content="ÑеÑдеÑно-ÑоÑÑдиÑÑÑе ÑакÑоÑÑ ÑиÑка"> 35 <meta property="article:tag" content="ÑпикаÑдиалÑÐ½Ð°Ñ Ð¶Ð¸ÑÐ¾Ð²Ð°Ñ ÑканÑ"> 36 <meta property="article:tag" content="гипеÑÑÑикемиÑ"> 37 <meta property="article:tag" content="инкÑеÑинÑ"> 38 <meta property="article:tag" content="ÑиÑзепаÑид"> 39 <meta property="article:tag" content="клиниÑеÑкий ÑлÑÑай"> 40 <meta property="article:section" content="ÐÐÐ ÐÐÐÐÐÐÐЯ"> 41 <meta name="citation_keywords" xml:lang="en" lang="en" content="obesity; arterial hypertension; dyslipidemia; cardiovascular risk factors; epicardial adipose tissue; hyperuricemia; incretins; tirzepatide; case report"/> 42 <meta name="citation_keywords" xml:lang="ru" lang="ru" content="ожиÑение; аÑÑеÑиалÑÐ½Ð°Ñ Ð³Ð¸Ð¿ÐµÑÑензиÑ; диÑлипидемиÑ; ÑеÑдеÑно-ÑоÑÑдиÑÑÑе ÑакÑоÑÑ ÑиÑка; ÑпикаÑдиалÑÐ½Ð°Ñ Ð¶Ð¸ÑÐ¾Ð²Ð°Ñ ÑканÑ; гипеÑÑÑикемиÑ; инкÑеÑинÑ; ÑиÑзепаÑид; клиниÑеÑкий ÑлÑÑай"/> 43 <link rel="canonical" href="https://www.med-sovet.pro/jour/article/view/10423" /> 44 <meta property="og:url" content="https://www.med-sovet.pro/jour/article/view/10423"> 45 <meta property="article:modified_time" content="2026-09-21T21:49:05Z"> 46 <meta property="article:published_time" content="2026-09-21T00:00:00Z"> 47 48 <link rel="schema.DC" href="http://purl.org/dc/elements/1.1/" /> 49 50 <meta name="DC.Contributor.Sponsor" xml:lang="en" lang="en" content=""/> 51 <meta name="DC.Contributor.Sponsor" xml:lang="ru" lang="ru" content=""/> 52 <meta name="DC.Creator.PersonalName" content="E. E. Sakhnova" xml:lang="en" lang="en"/> 53 <meta name="DC.Creator.PersonalName" content="Ð. Ð. Ð¡Ð°Ñ Ð½Ð¾Ð²Ð°" xml:lang="ru" lang="ru"/> 54 <meta name="DC.Creator.PersonalName" content="N. E. Gavrilova" xml:lang="en" lang="en"/> 55 <meta name="DC.Creator.PersonalName" content="Ð. Ð. ÐавÑилова" xml:lang="ru" lang="ru"/> 56 <meta name="DC.Creator.PersonalName" content="O. D. Ostroumova" xml:lang="en" lang="en"/> 57 <meta name="DC.Creator.PersonalName" content="Ð. Ð. ÐÑÑÑоÑмова" xml:lang="ru" lang="ru"/> 58 <meta name="DC.Creator.PersonalName" content="Ð. I. Kochetkov" xml:lang="en" lang="en"/> 59 <meta name="DC.Creator.PersonalName" content="Ð. Ð. ÐоÑеÑков" xml:lang="ru" lang="ru"/> 60 <meta name="DC.Creator.PersonalName" content="S. S. Telkova" xml:lang="en" lang="en"/> 61 <meta name="DC.Creator.PersonalName" content="С. С. Телкова" xml:lang="ru" lang="ru"/> 62 <meta name="DC.Creator.PersonalName" content="Yu. S. Moryakova" xml:lang="en" lang="en"/> 63 <meta name="DC.Creator.PersonalName" content="Ю. С. ÐоÑÑкова" xml:lang="ru" lang="ru"/> 64 65 <meta name="DC.Date.created" scheme="ISO8601" content="2026-09-21"/> 66 <meta name="DC.Date.dateSubmitted" scheme="ISO8601" content="2026-09-16"/> 67 <meta name="DC.Date.issued" scheme="ISO8601" content="2026-09-21"/> 68 <meta name="DC.Date.modified" scheme="ISO8601" content="2026-09-21"/> 69 <meta name="DC.Description" xml:lang="en" lang="en" content=" The aim of this publication is to demonstrate the efficacy of tirzepatide in a patient with obesity and obesity-associated comorbidities in a real-world clinical setting. A c
69ase report of a 36-year-old patient with obesity, arterial hypertension, impaired glucose tolerance, dyslipidemia, hyperuricemia, and metabolic dysfunction-associated steatotic liver disease is presented. At baseline, body weight was 126 kg, body mass index was 38 kg/m2, and waist circumference was 117 cm. The patient was recommended lifestyle modification and treatment with tirzepatide, with gradual dose escalation to 12.5 mg once weekly. After 15 months of therapy, body weight decreased to 91 kg (-27.8%), body mass index to 27.8 kg/m2, and waist circumference to 94 cm. Body composition analysis demonstrated a reduction in adipose tissue mass with preservation of skeletal muscle mass. Normalization of blood levels of glucose, lipids, uric acid, and blood pressure parameters was achieved during treatment. Echocardiography demonstrated a reduction in epicardial adipose tissue thickness. No clinically significant adverse events were observed throughout the treatment period. Tirzepatide may provide clinically meaningful benefits in the treatment of obesity in patients with cardiometabolic disorders. Its use is associated with substantial weight loss, improvement in glycemic control, lipid profile, and uric acid levels, as well as lower cardiovascular risk. Of particular interest is the reduction in adipose tissue mass while preserving skeletal muscle mass. Tirzepatide has shown multifaceted metabolic effects, along with manageable adverse profiles, which makes it a promising therapeutic agent for addressing obesity and associated comorbidities. "/> 70 <meta name="DC.Description" xml:lang="ru" lang="ru" content=" Ð¦ÐµÐ»Ñ Ð½Ð°ÑÑоÑÑей пÑбликаÑии â пÑодемонÑÑÑиÑоваÑÑ ÑÑÑекÑивноÑÑÑ Ð¿ÑÐ¸Ð¼ÐµÐ½ÐµÐ½Ð¸Ñ ÑиÑзепаÑида Ñ Ð¿Ð°ÑиенÑа Ñ Ð¾Ð¶Ð¸Ñением и аÑÑоÑииÑованнÑми комоÑбиднÑми ÑоÑÑоÑниÑми в ÑÑловиÑÑ ÑеалÑной клиниÑеÑкой пÑакÑики. ÐÑедÑÑавлено клиниÑеÑкое наблÑдение паÑиенÑа 36 Ð»ÐµÑ Ñ Ð¾Ð¶Ð¸Ñением II ÑÑепени, аÑÑеÑиалÑной гипеÑÑензией, наÑÑÑенной ÑолеÑанÑноÑÑÑÑ Ðº глÑкозе, гипеÑлипидемией, гипеÑÑÑикемией и меÑаболиÑеÑки аÑÑоÑииÑованной жиÑовой болезнÑÑ Ð¿ÐµÑени. ÐÑÑ Ð¾Ð´Ð½Ð¾ маÑÑа Ñела паÑиенÑа ÑоÑÑавлÑла 126 кг, Ð¸Ð½Ð´ÐµÐºÑ Ð¼Ð°ÑÑÑ Ñела â 38 кг/м2, окÑÑжноÑÑÑ Ñалии â 117 Ñм. ÐаÑиенÑÑ Ð±Ñли ÑÐµÐºÐ¾Ð¼ÐµÐ½Ð´Ð¾Ð²Ð°Ð½Ñ Ð¼Ð¾Ð´Ð¸ÑикаÑÐ¸Ñ Ð¾Ð±Ñаза жизни и ÑеÑÐ°Ð¿Ð¸Ñ ÑиÑзепаÑидом Ñ Ð¿Ð¾ÑÑепенной ÑиÑÑаÑией Ð´Ð¾Ð·Ñ Ð´Ð¾ 12,5 мг 1 Ñаз в неделÑ. ЧеÑез 15 меÑ. ÑеÑапии маÑÑа Ñела ÑнизилаÑÑ Ð´Ð¾ 91 кг (-27,8%), Ð¸Ð½Ð´ÐµÐºÑ Ð¼Ð°ÑÑÑ Ñела â до 27,8 кг/м2, окÑÑжноÑÑÑ Ñалии â до 94 Ñм. ÐÑмеÑено ÑлÑÑÑение композиÑионного ÑоÑÑава Ñела в виде ÑменÑÑÐµÐ½Ð¸Ñ Ð¼Ð°ÑÑÑ Ð¶Ð¸Ñовой Ñкани пÑи ÑÐ¾Ñ Ñанении мÑÑеÑного компоненÑа. Ðа Ñоне леÑÐµÐ½Ð¸Ñ Ð´Ð¾ÑÑигнÑÑа ноÑмализаÑÐ¸Ñ Ð¿Ð¾ÐºÐ°Ð·Ð°Ñелей Ñглеводного обмена, липидного пÑоÑилÑ, ÑÑÐ¾Ð²Ð½Ñ Ð¼Ð¾Ñевой киÑлоÑÑ Ð¸ аÑÑеÑиалÑного давлениÑ. Ðо даннÑм ÑÑ Ð¾ÐºÐ°ÑдиогÑаÑии оÑмеÑалоÑÑ ÑменÑÑение ÑолÑÐ¸Ð½Ñ ÑпикаÑдиалÑной жиÑовой Ñкани. ÐлиниÑеÑки знаÑимÑÑ Ð½ÐµÐ¶ÐµÐ»Ð°ÑелÑнÑÑ Ñвлений на пÑоÑÑжении пеÑиода наблÑÐ´ÐµÐ½Ð¸Ñ Ð·Ð°ÑегиÑÑÑиÑовано не бÑло. ТиÑзепаÑид ÑвлÑеÑÑÑ Ð¿ÐµÑÑпекÑивнÑм ÑеÑапевÑиÑеÑким инÑÑÑÑменÑом Ð´Ð»Ñ Ð»ÐµÑÐµÐ½Ð¸Ñ Ð¾Ð¶Ð¸ÑÐµÐ½Ð¸Ñ Ñ Ð¿Ð°ÑиенÑов Ñ ÐºÐ°ÑдиомеÑаболиÑеÑкими наÑÑÑениÑми. Ð ÑÑловиÑÑ ÑеалÑной пÑакÑики пÑименение пÑепаÑаÑа позволÑÐµÑ Ð´Ð¾ÑÑигаÑÑ Ð²ÑÑаженного ÑÐ½Ð¸Ð¶ÐµÐ½Ð¸Ñ Ð¼Ð°ÑÑÑ Ñела, ÑопÑовождаÑÑегоÑÑ Ð±Ð»Ð°Ð³Ð¾Ð¿ÑиÑÑной динамикой показаÑелей Ñглеводного, липидного и пÑÑинового обмена, а Ñакже Ñнижением ÑеÑдеÑно-ÑоÑÑдиÑÑого ÑиÑка. ÐÑобÑй инÑеÑÐµÑ Ð¿ÑедÑÑавлÑÐµÑ Ð²Ð¾Ð·Ð¼Ð¾Ð¶Ð½Ð¾ÑÑÑ ÑменÑÑÐµÐ½Ð¸Ñ Ð¶Ð¸Ñового компоненÑа маÑÑÑ Ñела пÑи ÑÐ¾Ñ Ñанении мÑÑеÑной Ñкани. ХоÑоÑÐ°Ñ Ð¿ÐµÑеноÑимоÑÑÑ ÑеÑапии и оÑÑÑÑÑÑвие знаÑимÑÑ Ð½ÐµÐ¶ÐµÐ»Ð°ÑелÑнÑÑ Ñвлений подÑвеÑждаÑÑ Ð²ÑÑокий ÑеÑапевÑиÑеÑкий поÑенÑиал ÑиÑзепаÑида Ñ Ð¿Ð°ÑиенÑов Ñ Ð¾ÑложненнÑм ожиÑением и комоÑбидной паÑологией. "/> 71 <meta name="DC.Format" scheme="IMT" content="application/pdf"/> 72 <meta name="DC.Identifier" content="10423"/> 73 <meta name="DC.Identifier.pageNumber" content="15-26"/> 74 <meta name="DC.Identifier.DOI" content="10.21518/ms2026-324"/> 75 <meta name="dc.identifier" content="doi:10.21518/ms2026-324"/>
76 <meta name="DC.Identifier.URI" content="https://www.med-sovet.pro/jour/article/view/10423"/> 77 <meta name="DC.Language" scheme="ISO639-1" content=""/> 78 <meta name="DC.Rights" xml:lang="en" lang="en" content=" Authors publishing their articles in this journal shall agree to the following: Authors reserve the copyright to the work and grant the journal a license to publish the work for the first time Creative Commons Attribution License (CC BY- NC-ND) , which allows other persons to distribute this work with the obligatory preservation of references to the authors of the original work and the original publication in this journal. Authors reserve the right to conclude separate contractual arrangements regarding the non-exclusive distribution of the work version in the form published here (for example, posting it in the instituteâs repository, publication in a book), with reference to its original publication in this journal. Authors have the right to post work on the Internet (for example, in the instituteâs repository or personal website) before and during the process of considering it by this journal, as this can result in a productive discussion and more references to this work. " /> 79 <meta name="DC.Source" xml:lang="en" lang="en" content="Meditsinskiy sovet = Medical Council"/> 80 <meta name="DC.Rights" xml:lang="ru" lang="ru" content=" ÐвÑоÑÑ, пÑбликÑÑÑие в данном жÑÑнале, ÑоглаÑаÑÑÑÑ Ñо ÑледÑÑÑим: ÐвÑоÑÑ ÑÐ¾Ñ ÑанÑÑÑ Ð·Ð° Ñобой авÑоÑÑкие пÑава на ÑабоÑÑ Ð¸ пÑедоÑÑавлÑÑÑ Ð¶ÑÑÐ½Ð°Ð»Ñ Ð¿Ñаво пеÑвой пÑбликаÑии ÑабоÑÑ Ð½Ð° ÑÑловиÑÑ Ð»Ð¸Ñензии Creative Commons Attribution License (CC BY- NC-ND) , коÑоÑÐ°Ñ Ð¿Ð¾Ð·Ð²Ð¾Ð»ÑÐµÑ Ð´ÑÑгим ÑаÑпÑоÑÑÑанÑÑÑ Ð´Ð°Ð½Ð½ÑÑ ÑабоÑÑ Ñ Ð¾Ð±ÑзаÑелÑнÑм ÑÐ¾Ñ Ñанением ÑÑÑлок на авÑоÑов оÑигиналÑной ÑабоÑÑ Ð¸ оÑигиналÑнÑÑ Ð¿ÑбликаÑÐ¸Ñ Ð² жÑÑнале. ÐвÑоÑÑ ÑÐ¾Ñ ÑанÑÑÑ Ð¿Ñаво заклÑÑаÑÑ Ð¾ÑделÑнÑе конÑÑакÑнÑе договоÑÑнноÑÑи, каÑаÑÑиеÑÑ Ð½Ðµ-ÑкÑклÑзивного ÑаÑпÑоÑÑÑÐ°Ð½ÐµÐ½Ð¸Ñ Ð²ÐµÑÑии ÑабоÑÑ Ð² опÑбликованном виде (напÑимеÑ, ÑазмеÑение ее в инÑÑиÑÑÑÑком Ñ ÑанилиÑе, пÑбликаÑÐ¸Ñ Ð² книге), Ñо ÑÑÑлкой на ее оÑигиналÑнÑÑ Ð¿ÑбликаÑиÑ. ÐвÑоÑÑ Ð¸Ð¼ÐµÑÑ Ð¿Ñаво ÑазмеÑаÑÑ ÑабоÑÑ Ð² ÑеÑи ÐнÑеÑÐ½ÐµÑ (напÑÐ¸Ð¼ÐµÑ Ð² инÑÑиÑÑÑÑком Ñ ÑанилиÑе или пеÑÑоналÑном ÑайÑе) до и во вÑÐµÐ¼Ñ Ð¿ÑоÑеÑÑа ÑаÑÑмоÑÑÐµÐ½Ð¸Ñ ÐµÐµ даннÑм жÑÑналом, Ñак как ÑÑо Ð¼Ð¾Ð¶ÐµÑ Ð¿ÑивеÑÑи к пÑодÑкÑÐ¸Ð²Ð½Ð¾Ð¼Ñ Ð¾Ð±ÑÑÐ¶Ð´ÐµÐ½Ð¸Ñ Ð¸ болÑÑÐµÐ¼Ñ ÐºÐ¾Ð»Ð¸ÑеÑÑÐ²Ñ ÑÑÑлок на даннÑÑ ÑабоÑÑ. (См. The Effect of Open Access ). " /> 81 <meta name="DC.Source" xml:lang="ru" lang="ru" content="ÐедиÑинÑкий СовеÑ"/> 82 <meta name="DC.Source.ISSN" content="2658-5790"/> 83 <meta name="DC.Source.Issue" content="13"/> <meta name="DC.Source.URI" content="https://www.med-sovet.pro/jour"/> 84 <meta name="DC.Source.Volume" content="0"/> <meta name="DC.Subject" xml:lang="en" lang="en" content="obesity"/> 85 <meta name="DC.Subject" xml:lang="en" lang="en" content="arterial hypertension"/> 86 <meta name="DC.Subject" xml:lang="en" lang="en" content="dyslipidemia"/> 87 <meta name="DC.Subject" xml:lang="en" lang="en" content="cardiovascular risk factors"/> 88 <meta name="DC.Subject" xml:lang="en" lang="en" content="epicardial adipose tissue"/> 89 <meta name="DC.Subject" xml:lang="en" lang="en" content="hyperuricemia"/> 90 <meta name="DC.Subject" xml:lang="en" lang="en" content="incretins"/> 91 <meta name="DC.Subject" xml:lang="en" lang="en" content="tirzepatide"/> 92 <meta name="DC.Subject" xml:lang="en" lang="en" content="case report"/> 93 <meta name="DC.Subject" xml:lang="ru" lang="ru" content="ожиÑение"/> 94 <meta name="DC.Subject" xml:lang="ru" lang="ru" content="аÑÑеÑиалÑÐ½Ð°Ñ Ð³Ð¸Ð¿ÐµÑÑензиÑ"/> 95 <meta name="DC.Subject" xml:lang="ru" lang="ru" content="диÑлипидемиÑ"/> 96 <meta name="DC.Subject" xml:lang="ru" lang="ru" content="ÑеÑдеÑно-ÑоÑÑдиÑÑÑе ÑакÑоÑÑ ÑиÑка"/> 97 <meta name="DC.Subject" xml:lang="ru" lang="ru" content="ÑпикаÑдиалÑÐ½Ð°Ñ Ð¶Ð¸ÑÐ¾Ð²Ð°Ñ ÑканÑ"/> 98 <meta name="DC.Subject" xml:lang="ru" lang="ru" content="гипеÑÑÑикемиÑ"/> 99 <meta name="DC.Subject" xml:lang="ru" lang="ru" content="инкÑеÑинÑ"/> 100 <meta name="DC.Subject" xml:lang="ru" lang="ru" content="ÑиÑзепаÑид"/> 101 <meta name="DC.Subject" xml:lang="ru" lang="ru" content="клиниÑеÑкий ÑлÑÑай"/> 102 <meta name="DC.Title" xml:lang="ru" lang="ru" content="ÐÑÑекÑивноÑÑÑ Ð¸ безопаÑноÑÑÑ ÑиÑзепаÑида в леÑении ожиÑÐµÐ½Ð¸Ñ Ð¸ аÑÑоÑииÑованнÑÑ Ñ Ð½Ð¸Ð¼ комоÑбиднÑÑ ÑоÑÑоÑний"/> 103 <meta name="DC.Title.Alternative" xml:lang="en" lang="en" content="Efficacy and safety of tirzepatide in the treatment of obesity and obesity-associated comorbidities"/> 104 <meta name="DC.Type" content="Text.Serial.Journal"/> 105 <meta name="DC.Type.articleType" content="ÐÐÐ ÐÐÐÐÐÐÐЯ"/> 106 <meta name="gs_meta_revision" content="1.1" /> 107 <meta name="citation_journal_title" xml:lang="en" lang="en" content="Meditsinskiy sovet = Medical Council"/> 108 <meta name="citation_journal_title" xml:lang="ru" lang="ru" content="ÐедиÑинÑкий СовеÑ"/> 109 <meta name="citation_issn" content="2658-5790"/> 110 111 <meta name="citation_author" xml:lang="en" lang="en" content="E. E. Sakhnova"/> 112 <meta name="citation_author_institution" xml:lang="en" lang="en" content="Russian Medical Academy of Continuous Professional Education; 113Scandinavian Health Center LLC"/> 114 115 <meta name="citation_author" xml:lang="en" lang="en" content="N. E. Gavrilova"/> 116 <meta name="citation_author_institution" xml:lang="en" lang="en" content="Russian Medical Academy of Continuous Professional Education; 117Scandinavian Health Center LLC"/> 118 119 <meta name="citation_author" xml:lang="en" lang="en" content="O. D. Ostroumova"/> 120 <meta name="citation_author_institution" xml:lang="en" lang="en" content="Russian Medical Academy of Continuous Professional Education;
121Sechenov First Moscow State Medical University (Sechenov University)"/> 122 123 <meta name="citation_author" xml:lang="en" lang="en" content="Ð. I. Kochetkov"/> 124 <meta name="citation_author_institution" xml:lang="en" lang="en" content="Russian Medical Academy of Continuous Professional Education"/> 125 126 <meta name="citation_author" xml:lang="en" lang="en" content="S. S. Telkova"/> 127 <meta name="citation_author_institution" xml:lang="en" lang="en" content="Russian Medical Academy of Continuous Professional Education"/> 128 129 <meta name="citation_author" xml:lang="en" lang="en" content="Yu. S. Moryakova"/> 130 <meta name="citation_author_institution" xml:lang="en" lang="en" content="Russian Medical Academy of Continuous Professional Education; 131Scandinavian Health Center LLC"/> 132 133 <meta name="citation_title" xml:lang="en" lang="en" content="Efficacy and safety of tirzepatide in the treatment of obesity and obesity-associated comorbidities"/> 134 135 <meta name="citation_author" xml:lang="ru" lang="ru" content="Ð. Ð. Ð¡Ð°Ñ Ð½Ð¾Ð²Ð°"/> 136 <meta name="citation_author_institution" xml:lang="ru" lang="ru" content="РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; 137ÐÐР«СкандинавÑкий ЦенÑÑ ÐдоÑовÑÑ»"/> 138 139 <meta name="citation_author" xml:lang="ru" lang="ru" content="Ð. Ð. ÐавÑилова"/> 140 <meta name="citation_author_institution" xml:lang="ru" lang="ru" content="РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; 141ÐÐР«СкандинавÑкий ЦенÑÑ ÐдоÑовÑÑ»"/> 142 143 <meta name="citation_author" xml:lang="ru" lang="ru" content="Ð. Ð. ÐÑÑÑоÑмова"/> 144 <meta name="citation_author_institution" xml:lang="ru" lang="ru" content="РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; 145ÐеÑвÑй ÐоÑковÑкий гоÑÑдаÑÑÑвеннÑй медиÑинÑкий ÑнивеÑÑиÑÐµÑ Ð¸Ð¼ÐµÐ½Ð¸ Ð.Ð. СеÑенова (СеÑеновÑкий УнивеÑÑиÑеÑ)"/> 146 147 <meta name="citation_author" xml:lang="ru" lang="ru" content="Ð. Ð. ÐоÑеÑков"/> 148 <meta name="citation_author_institution" xml:lang="ru" lang="ru" content="РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ"/> 149 150 <meta name="citation_author" xml:lang="ru" lang="ru" content="С. С. Телкова"/> 151 <meta name="citation_author_institution" xml:lang="ru" lang="ru" content="РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ"/> 152 153 <meta name="citation_author" xml:lang="ru" lang="ru" content="Ю. С. ÐоÑÑкова"/> 154 <meta name="citation_author_institution" xml:lang="ru" lang="ru" content="РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; 155ÐÐР«СкандинавÑкий ЦенÑÑ ÐдоÑовÑÑ»"/> 156 157 <meta name="citation_title" xml:lang="ru" lang="ru" content="ÐÑÑекÑивноÑÑÑ Ð¸ безопаÑноÑÑÑ ÑиÑзепаÑида в леÑении ожиÑÐµÐ½Ð¸Ñ Ð¸ аÑÑоÑииÑованнÑÑ Ñ Ð½Ð¸Ð¼ комоÑбиднÑÑ ÑоÑÑоÑний"/> 158 <meta name="citation_date" content="2026/09/21"/> 159 160 <meta name="citation_volume" content="0"/> 161 <meta name="citation_issue" content="13"/> 162 163 <meta name="citation_firstpage" content="15-26"/> 164 <meta name="citation_doi" content="10.21518/ms2026-324"/> 165 <meta name="citation_abstract_html_url" content="https://www.med-sovet.pro/jour/article/view/10423"/> 166 <meta name="citation_fulltext_html_url" content="https://www.med-sovet.pro/jour/article/view/10423"/> 167 <meta name="citation_keywords" xml:lang="en" lang="en" content="obesity"/> 168 <meta name="citation_keywords" xml:lang="en" lang="en" content="arterial hypertension"/> 169 <meta name="citation_keywords" xml:lang="en" lang="en" content="dyslipidemia"/> 170 <meta name="citation_keywords" xml:lang="en" lang="en" content="cardiovascular risk factors"/> 171 <meta name="citation_keywords" xml:lang="en" lang="en" content="epicardial adipose tissue"/> 172 <meta name="citation_keywords" xml:lang="en" lang="en" content="hyperuricemia"/> 173 <meta name="citation_keywords" xml:lang="en" lang="en" content="incretins"/> 174 <meta name="citation_keywords" xml:lang="en" lang="en" content="tirzepatide"/> 175 <meta name="citation_keywords" xml:lang="en" lang="en" content="case report"/> 176 <meta name="citation_keywords" xml:lang="ru" lang="ru" content="ожиÑение"/> 177 <meta name="citation_keywords" xml:lang="ru" lang="ru" content="аÑÑеÑиалÑÐ½Ð°Ñ Ð³Ð¸Ð¿ÐµÑÑензиÑ"/> 178 <meta name="citation_keywords" xml:lang="ru" lang="ru" content="диÑлипидемиÑ"/> 179 <meta name="citation_keywords" xml:lang="ru" lang="ru" content="ÑеÑдеÑно-ÑоÑÑдиÑÑÑе ÑакÑоÑÑ ÑиÑка"/> 180 <meta name="citation_keywords" xml:lang="ru" lang="ru" content="ÑпикаÑдиалÑÐ½Ð°Ñ Ð¶Ð¸ÑÐ¾Ð²Ð°Ñ ÑканÑ"/> 181 <meta name="citation_keywords" xml:lang="ru" lang="ru" content="гипеÑÑÑикемиÑ"/> 182 <meta name="citation_keywords" xml:lang="ru" lang="ru" content="инкÑеÑинÑ"/> 183 <meta name="citation_keywords" xml:lang="ru" lang="ru" content="ÑиÑзепаÑид"/> 184 <meta name="citation_keywords" xml:lang="ru" lang="ru" content="клиниÑеÑкий ÑлÑÑай"/> 185 <meta name="citation_pdf_url" content="https://www.med-sovet.pro/jour/article/download/10423/8703"/>
185 186 187 188 189 <meta http-equiv="X-UA-Compatible" content="IE=edge" /> 190 <meta property="og:site_name" content="ÐедиÑинÑкий СовеÑ" /> 191 <meta property="og:image" content="https://www.med-sovet.pro/resources/journal_avatar.png"/> 192 <meta property="og:image:width" content="1200"/> 193 <meta property="og:image:height" content="1200"/> 194 195 <link rel="stylesheet" href="https://www.med-sovet.pro/lib/pkp/styles/pkp.css" type="text/css" /> 196 <link rel="stylesheet" href="https://www.med-sovet.pro/lib/pkp/styles/common.css" type="text/css" /> 197 <link rel="stylesheet" href="https://www.med-sovet.pro/assets/css/common.css" type="text/css" /> 198 <link rel="stylesheet" href="https://www.med-sovet.pro/assets/css/compiled.css" type="text/css" /> 199 <link rel="stylesheet" href="https://www.med-sovet.pro/assets/css/slick.css" type="text/css" /> 200 <link rel="stylesheet" href="https://www.med-sovet.pro/assets/css/slick-theme.css" type="text/css" /> 201 <link rel="stylesheet" href="https://www.med-sovet.pro/assets/css/select2.min.css" type="text/css" /> 202 <link rel="stylesheet" href="https://www.med-sovet.pro/assets/css/overall.css?v=20260921182516" type="text/css" /> 203 <link rel="stylesheet" href="https://www.med-sovet.pro/assets/css/template.css?v=20260921182516" type="text/css" /> 204 <link rel="stylesheet" href="https://www.med-sovet.pro/styles/branding.css" type="text/css" /> 205 206 <!-- Base Jquery --> 207
207<script type="text/javascript" src="https://www.med-sovet.pro/assets/js/jquery_legacy/jquery.min.js"></script>
207 208
208<script type="text/javascript" src="https://www.med-sovet.pro/assets/js/jquery_legacy/jquery-ui.min.js"></script>
208 209 210 211 <!-- Default global locale keys for JavaScript --> 212
213<script type="text/javascript"> 214 jQuery.pkp = jQuery.pkp || { }; 215 jQuery.pkp.locale = { }; 216 217 jQuery.pkp.locale.form_dataHasChanged = 'ÐаннÑе ÑÑой ÑоÑÐ¼Ñ Ð±Ñли измененÑ. ÐÑе Ñавно пÑодолжиÑÑ?'; 218 </script>
218 219 <!-- Compiled scripts --> 220
220<script type="text/javascript" src="https://www.med-sovet.pro/assets/js/pkp.min.js?v=20260921182516"></script>
220 221 222 <!-- Add javascript required for font sizer --> 223
223<script type="text/javascript"> 224 <!-- 225 $(function(){ 226 fontSize("#sizer", "body", 9, 16, 32, ""); // Initialize the font sizer 227 }); 228 // --> 229 </script>
229 230 231 <!-- Form validation --> 232
232<script src="https://smartcaptcha.yandexcloud.net/captcha.js" defer></script>
232 233
233<script type="text/javascript" src="https://www.med-sovet.pro/lib/pkp/js/lib/jquery/plugins/validate/jquery.validate.js"></script>
233 234 235
235<script type="text/javascript" src="https://www.med-sovet.pro/resources/string_functions.js"></script>
235 236
236<script type="text/javascript"> 237 <!-- 238 // initialise plugins 239 240 $(function(){ 241 jqueryValidatorI18n("https://www.med-sovet.pro", "ru_RU"); // include the appropriate validation localization 242 243 $(".tagit").click(function() { 244 $(this).find('input').focus(); 245 }); 246 }); 247 // --> 248 249 $(document).ready(function() { 250 $('#simpleSearchForm').attr('action', "https://www.med-sovet.pro/jour/search/search") 251 }); 252 </script>
252 253 254 255 256
256<script language="javascript" type="text/javascript" src="https://www.med-sovet.pro/plugins/generic/tinymce/tinymce/tinymce.min.js"></script>
256 257
257<script language="javascript" type="text/javascript"> 258 tinyMCE.init({ 259 entity_encoding : "raw", 260 contextmenu: false, 261 menubar: "edit insert view format table tools", 262 plugins : "paste,fullscreen,lists,link,help,code,table,code,autolink,advlist,charmap,hr,searchreplace,wordcount,visualblocks,visualchars,textcolor,nonbreaking", 263 paste_data_images : false, 264 mode : "exact", 265 language : "ru", 266 elements : "email_body", 267 relative_urls : false, 268 remove_script_host : false, 269 indent: false, 270 browser_spellcheck: true, 271 paste_auto_cleanup_on_paste : true, 272 apply_source_formatting : false, 273 forced_root_block : "p", 274 theme : "silver", 275 branding: false, 276 statusbar: true, 277 toolbar: "bold italic underline bullist numlist subscript superscript nonbreaking| link unlink code fullscreen image| alignleft aligncenter alignright al
277ignjustify", 278 theme_advanced_buttons1 : "cut,copy,paste,|,bold,italic,underline,bullist,numlist,sub,sup,|,link,unlink,help,code,fullscreen,image", 279 theme_advanced_buttons2 : "", 280 theme_advanced_buttons3 : "" 281 }); 282 </script>
282 283 284
284<script type="text/javascript" src="https://www.med-sovet.pro/assets/js/relatedItems.js"></script>
284 285
285<script type="text/javascript" src="https://www.med-sovet.pro/assets/js/inlinePdf.js"></script>
285 286
286<script type="text/javascript" src="https://www.med-sovet.pro/assets/js/pdfobject.js"></script>
286 287 288 289<!-- Standard Favicon --> 290<link rel="icon" type="image/x-icon" href="/favicon.ico" /> 291 292<!-- For Opera Coast: --> 293<link rel="icon" sizes="228x228" href="/favicon-coast.png" /> 294 295<!-- For Chrome for Android: --> 296<link rel="icon" sizes="192x192" href="/touch-icon-192x192.png"> 297 298<!-- For Windows 8: --> 299<meta name="msapplication-TileColor" content="#ef0303" /> 300<meta name="msapplication-TileImage" content="/mstile-144x144.png" /> 301<meta name="msapplication-config" content="/browserconfig.xml" /> 302 303<!-- For iPhone 6 Plus with @3à display: --> 304<link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon-180x180.png"> 305<link rel="apple-touch-icon-precomposed" sizes="180x180" href="/apple-touch-icon-180x180-precomposed.png"> 306 307<!-- For iPad with @2à display running iOS ⥠7: --> 308<link rel="apple-touch-icon" sizes="152x152" href="/apple-touch-icon-152x152.png"> 309<link rel="apple-touch-icon-precomposed" sizes="152x152" href="/apple-touch-icon-152x152-precomposed.png"> 310 311<!-- For iPad with @2à display running iOS ⤠6: --> 312<link rel="apple-touch-icon" sizes="144x144" href="/apple-touch-icon-144x144.png"> 313<link rel="apple-touch-icon-precomposed" sizes="144x144" href="/apple-touch-icon-144x144-precomposed.png"> 314 315<!-- For iPhone with @2à display running iOS ⥠7: --> 316<link rel="apple-touch-icon" sizes="120x120" href="/apple-touch-icon-120x120.png"> 317<link rel="apple-touch-icon-precomposed" sizes="120x120" href="/apple-touch-icon-120x120-precomposed.png"> 318 319<!-- For iPhone with @2à display running iOS ⤠6: --> 320<link rel="apple-touch-icon" sizes="114x114" href="/apple-touch-icon-114x114.png"> 321<link rel="apple-touch-icon-precomposed" sizes="114x114" href="/apple-touch-icon-114x114-precomposed.png"> 322 323<!-- For the iPad mini and the first- and second-generation iPad (@1à display) on iOS ⥠7: --> 324<link rel="apple-touch-icon" sizes="76x76" href="/apple-touch-icon-76x76.png"> 325<link rel="apple-touch-icon-precomposed" sizes="76x76" href="/apple-touch-icon-76x76-precomposed.png"> 326 327<!-- For the iPad mini and the first- and second-generation iPad (@1à display) on iOS ⤠6: --> 328<link rel="apple-touch-icon" sizes="72x72" href="/apple-touch-icon-72x72.png"> 329<link rel="apple-touch-icon-precomposed" sizes="72x72" href="/apple-touch-icon-72x72-precomposed.png"> 330 331<!-- For non-Retina iPhone, iPod Touch, and Android 2.1+ devices: --> 332<link rel="apple-touch-icon" href="/apple-touch-icon.png"><!-- 57Ã57px --> 333<link rel="apple-touch-icon-precomposed" href="/apple-touch-icon-precomposed.png"><!-- 57Ã57px --> 334 335<!-- favicon png --> 336<link rel="icon" type="image/png" href="/favicon-16x16.png" sizes="16x16"> 337<link rel="icon" type="image/png" href="/favicon-32x32.png" sizes="32x32"> 338<link rel="icon" type="image/png" href="/favicon-48x48.png" sizes="48x48"> 339<link rel="icon" type="image/png" href="/favicon-64x64.png" sizes="64x64"> 340<link rel="icon" type="image/png" href="/favicon-96x96.png" sizes="96x96"> 341<link rel="icon" type="image/png" href="/favicon-128x128.png" sizes="128x128"> 342<link rel="icon" type="image/png" href="/favicon-160x160.png" sizes="160x160"> 343<link rel="icon" type="image/png" href="/favicon-192x192.png" sizes="192x192"> 344<link rel="icon" type="image/png" href="/favicon-256x256.png" sizes="256x256"> 345 <link rel="alternate" hreflang="en" href="https://www.med-sovet.pro/jour/article/view/10423?locale=en_US"/> 346 <link rel="alternate" hreflang="ru" href="https://www.med-sovet.pro/jour/article/view/10423?locale=ru_RU"/> 347<link rel="alternate" hreflang="x-default" href="https://www.med-sovet.pro/jour/article/view/10423"/> 348</head> 349<body> 350<div id="container"> 351 352 <nav class="navbar"> 353 <div class="container"> 354 <div class="wrapper"> 355 356 <div class="title"> 357 ÐедиÑинÑкий СовеÑ<br/> 358 Meditsinskiy sovet 359 </div> 360 361 362 <div class="issn"> 363 <span id="issnp" data-id="2079-701X">ISSN <a href="https://portal.issn.org/resource/ISSN/2079-701X" target="_blank">2079-701X</a> (Print)</span><br/>
363 <span id="issne" data-id="2658-5790">ISSN <a href="https://portal.issn.org/resource/ISSN/2658-5790" target="_blank">2658-5790</a> (Online)</span><br/> </div> 364 365 <a href="#" class="userBlock" onclick="$('#fullback').css('display', 'flex'); $('#sidebar-username').focus(); return false;"> 366 <span>ÐойÑи</span> 367 </a> 368 369 <div class="language"> 370 <a href='#' class="toggler" data="https://www.med-sovet.pro/jour/user/setLocale/en_US?source=%2Fjour%2Farticle%2Fview%2F10423" class="en" >eng</a> 371 | <a href='#' onclick="return false;" class="ru current" >ÑÑÑ</a> 372
372<script> 373 $(document).ready(function(){ 374 $(".language a.toggler").click(function(){ 375 var url = $(this).attr('data'); 376 var hash = encodeURI(window.location.hash); 377 location.href=(url+hash); 378 return false; 379 }); 380 }); 381 382 </script>
382 383 <input id="currentLocale" value="ru_RU" type="hidden"> 384 </div> 385 386 </div> 387 </div> 388 </nav> 389 390 <div class="fullback" id="image-back"> 391 <div class="image-wrapper"> 392 <img src="" alt="Preview" class="preview"/> 393 <a class="close-cross" href="#" onclick="$('#image-back').hide(); return false;"></a> 394 </div> 395 </div> 396 397 <div class="fullback" id="fullback"> 398 <div class="modal userLogin"> 399 <a class="close-cross" href="#" onclick="$('#fullback').hide(); return false;"></a> 400 <h3 class="blockTitle">ÐойÑи</h3> 401 <form method="post" action="https://www.med-sovet.pro/jour/login/signIn"> 402 <table> 403 <tr> 404 <td class="label"><label for="sidebar-username">Ðогин</label></td> 405 <td><input type="text" id="sidebar-username" name="username" value="" size="12" maxlength="32" class="textField" /></td> 406 </tr> 407 <tr> 408 <td class="label"><label for="sidebar-password">ÐаÑолÑ</label></td> 409 <td><input type="password" id="sidebar-password" name="password" value="" size="12" maxlength="32" class="textField" autocomplete="on"/></td> 410 </tr> 411 <tr> 412 <td class="label"></td> 413 <td><input type="checkbox" id="remember" name="remember" value="1" /> <label class="sans" for="remember">ÐапомниÑÑ Ð¼ÐµÐ½Ñ</label></td> 414 </tr> 415 416 417 <tr> 418 <td colspan="2"> 419 <div class="links"> 420 <a href="https://www.med-sovet.pro/jour/user/register">РегиÑÑÑаÑÐ¸Ñ Ð½Ð¾Ð²Ð¾Ð³Ð¾ полÑзоваÑелÑ</a> 421 <a href="https://www.med-sovet.pro/jour/login/lostPassword">ÐабÑли ÐÐ°Ñ Ð¿Ð°ÑолÑ?</a> 422 </div> 423 </td> 424 <tr> 425 <td></td> 426 <td><input type="submit" value="ÐÑ Ð¾Ð´" class="button" /></td> 427 </tr> 428 </table> 429 </form> 430 </div> 431 </div> 432 <div class="head"> 433 <div class="container hero"> 434 <div class="logo"> 435 <div class="container"> 436 <img src="https://www.med-sovet.pro/public/journals/1/homeHeaderLogoImage_ru_RU.png" usemap="#logobar"/> 437 </div> 438 </div> 439 <div class="wrapper logoed"> 440 <a href="https://www.med-sovet.pro/jour" class="headerLink"> 441 <h2 class="jtitle"> 442 ÐедиÑинÑкий Ð¡Ð¾Ð²ÐµÑ 443 </h2></a> 444 <form id="simpleSearchForm" class="headSearch" method="get"> 445 <table id="simpleSearchInput"><tr><td> 446
446<script type="text/javascript"> 447 448 $(function() { 449 $('#simpleQueryAutocomplete').pkpHandler( 450 '$.pkp.plugins.generic.lucene.LuceneAutocompleteHandler', 451 { 452 sourceUrl: "https://www.med-sovet.pro/jour/lucene/queryAutocomplete", 453 searchForm: "simpleSearchForm" 454 }); 455 }); 456</script>
456 457<span id="simpleQueryAutocomplete"> 458 <input type="text" id="simpleQuery_input" name="simpleQuery" size="15" maxlength="255" value="" class="textField" /> 459 <input type="hidden" id="simpleQuery" name="simpleQuery_hidden" value="" /> 460
460<script type="text/javascript"> 461 $('#simpleQuery_input').attr('name', 'simpleQuery_input'); 462 $('#simpleQuery').attr('name', 'simpleQuery'); 463 </script>
463 464</span> 465 <input type="hidden" name="searchField" value="query"/> 466 <input type="submit" value="" class="button" /> 467 </td></tr></table> 468 </form> 469 <div class="clear"></div> 470 <a class="search" href="https://www.med-sovet.pro/jour/search/search">РаÑÑиÑеннÑй поиÑк</a> 471 </div> 472 </div> 473 </div> 474 475 <div class="mainMenu" id="navbarWrapper"> 476 <div class="mobile-view container"> 477 <ul><li><a href="https://www.med-sovet.pro/jour/index"><img src="/assets/img/home.svg" alt="ÐлавнаÑ"></a></li> 478 <li><a href="#" onclick="$('#mobile-menu, .journalInfo').toggle(); return false;"><img src="/assets/img/sandwich.svg" alt="ÐÑÑÑÑÐ°Ñ Ð½Ð°Ð²Ð¸Ð³Ð°ÑиÑ"></a></li> 479 <li id="archives"><a href="https://www.med-sovet.pro/jour/issue/archive">ÐÑÑ Ð¸Ð²</a></li> 480 </ul> 481 </div> 482 <div class="container" id="float-menu"> 483 <div id="mobile-menu"> 484 <div id="navbar"> 485 <ul class="menu"> 486 <li id="home"><a href="https://www.med-sovet.pro/jour">ÐлавнаÑ</a></li> 487 <li id="about"><a href="https://www.med-sovet.pro/jour/about">РжÑÑнале</a></li> 488 489 490 <li id="current"><a href="https://www.med-sovet.pro/jour/issue/current">Свежий номеÑ</a></li> 491 <li id="archives"><a href="https://www.med-sovet.pro/jour/issue/archive">ÐÑÑ Ð¸Ð²</a></li> 492 493 <li id="announcements"><a href="https://www.med-sovet.pro/jour/announcement">ÐовоÑÑи</a></li> 494 495 496 497 <li class="navItem" id="navItem-0"><a href="http://med-sovet.pro/jour/pages/view/answer">ÐÑÐ°Ð»Ð¾Ð½Ñ Ð¾ÑвеÑов</a></li> 498 <li class="navItem" id="navItem-1"><a href="https://med-sovet.pro/jour/issue/view/248">ÐÑинÑÑо в пеÑаÑÑ</a></li> 499 </ul> 500</div> 501 502<div class="menu" id="sidebarMenu"> 503 <ul> 504 <li id="sidebar_submit"><a class="submitArticle" href="https://www.med-sovet.pro/jour/author/submit/1">ÐÑпÑавиÑÑ ÑÑаÑÑÑ</a></li> <li id="sidebar_author"><a href="https://www.med-sovet.pro/jour/about/submissions#authorGuidelines">ÐÑавила Ð´Ð»Ñ Ð°Ð²ÑоÑов</a></li> 505 <li id="sidebar_editorialc"><a href="https://www.med-sovet.pro/jour/pages/view/EditorialC">РедакÑиÑ</a></li> 506 <li id="sidebar_editorials" style="display:none"><a href="https://www.med-sovet.pro/jour/pages/view/EditorialS">РедакÑионнÑй ÑовеÑ</a></li> 507 <li id="sidebar_policy"><a href="https://www.med-sovet.pro/jour/about/editorialPolicies#custom-0">РеÑензиÑование</a></li> 508 <li id="sidebar_ethics"><a href="https://www.med-sovet.pro/jour/about/editorialPolicies#custom-1">ÐÑика пÑбликаÑий</a></li> 509 </ul> 510</div> 511 </div> 512 </div> 513 </div> 514 515 516 <div id="body" class="body"> 517 <div class="container flex"> 518 <div id="main" class="main"> 519 520 521 522 <div id="breadcrumb"> 523 <a href="https://www.med-sovet.pro/jour/index" target="_parent">ÐлавнаÑ</a> > 524 <a href="https://www.med-sovet.pro/jour/issue/view/385" target="_parent">â 13 (2026)</a> > <a href="https://www.med-sovet.pro/jour/article/view/10423/0" class="current" target="_parent">Ð¡Ð°Ñ Ð½Ð¾Ð²Ð°</a> 525 </div> 526 527 528 529 <div id="content"> 530 531 532 533 534 535 536 537 <div id="topBar"> 538 </div> 539 540 541 <div id="articleTitle"> 542 <h1>ÐÑÑекÑивноÑÑÑ Ð¸ безопаÑноÑÑÑ ÑиÑзепаÑида в леÑении ожиÑÐµÐ½Ð¸Ñ Ð¸ аÑÑоÑииÑованнÑÑ Ñ Ð½Ð¸Ð¼ комоÑбиднÑÑ ÑоÑÑоÑний 543 </h1> 544 545 </div> 546 547 <div id="authorString"><em> 548 <a title="Ð. Ð. Ð¡Ð°Ñ Ð½Ð¾Ð²Ð°" href="http://orcid.org/0000-0002-7102-5323" target="_blank"><img src="/resources/orcid.png"></a> <a rel="nofollow" href='/index.php/jour/search?authors=Ð. AND Ð. AND Ð¡Ð°Ñ Ð½Ð¾Ð²Ð°'> 549 Ð. Ð. Ð¡Ð°Ñ Ð½Ð¾Ð²Ð°</a>, <a title="Ð. Ð. ÐавÑилова" href="http://orcid.org/0000-0003-4624-9189" target="_blank"><img src="/resources/orcid.png"></a> <a rel="nofollow" href='/index.php/jour/search?authors=Ð. AND Ð. AND ÐавÑилова'> 550 Ð. Ð. ÐавÑилова</a>, <a title="Ð. Ð. ÐÑÑÑоÑмова" href="http://orcid.org/0000-0002-0795-8225" target="_blank"><img src="/resources/orcid.png"></a> <a rel="nofollow" href='/index.php/jour/search?authors=Ð. AND Ð. AND ÐÑÑÑоÑмова'> 551 Ð. Ð. ÐÑÑÑоÑмова</a>, <a title="Ð. Ð. ÐоÑеÑков" href="http://orcid.org/0000-0001-5801-3742" target="_blank"><img src="/resources/orcid.png"></a> <a rel="nofollow" href='/index.php/jour/search?authors=Ð. AND Ð. AND ÐоÑеÑков'> 552 Ð. Ð. ÐоÑеÑков</a>, <a title="С. С. Телкова" href="http://orcid.org/0000-0003-1439-7371" target="_blank"><img src="/resources/orcid.png"></a> <a rel="nofollow" href='/index.php/jour/search?authors=С. AND С. AND Телкова'> 553 С. С. Телкова</a>, <a title="Ю. С. ÐоÑÑкова" href="http://orcid.org/0009-0009-0029-4209" target="_blank"><img src="/resources/orcid.png"></a> <a rel="nofollow" href='/index.php/jour/search?authors=Ю. AND С. AND ÐоÑÑкова'> 554 Ю. С. ÐоÑÑкова</a> </em></div> 555 556 557 558 <p><a id="pub-id::doi" href="https://doi.org/10.21518/ms2026-324" aria-label="DOI for ÐÑÑекÑивноÑÑÑ Ð¸ безопаÑноÑÑÑ ÑиÑзепаÑида в леÑении ожиÑÐµÐ½Ð¸Ñ Ð¸ аÑÑоÑииÑованнÑÑ Ñ Ð½Ð¸Ð¼ комоÑбиднÑÑ ÑоÑÑоÑний" >https://doi.org/10.21518/ms2026-324</a></p> 559 560 <div class="banner"> 561 562 </div> 563 <div id="articleFullText"> 564
564<script src="https://yastatic.net/es5-shims/0.0.2/es5-shims.min.js"></script>
564 565
565<script src="https://yastatic.net/share2/share.js"></script>
565 566 <div class="ya-share2 yashare-auto-init" data-services="messenger,odnoklassniki,lj,telegram,vkontakte" data-copy="extraItem" data-size="s"></div> 567 <h2 class="fullsize">ÐолнÑй ÑекÑÑ:<a class="full_toggle" onclick="toggleFullWidth()"></a></h2> 568 <div class="fulltext"> 569 <a class="galley-link" href="https://www.med-sovet.pro/jour/article/view/10423/8703" class="file PDF ru_RU PDF (Rus)" target="_parent">PDF (Rus)</a> 570 571 <a class="qrcode-link galley-link" href="#" onclick="$('#qr-back').show(); return false;"><div id="qrcode-thumb"></div>ÑгенеÑиÑоваÑÑ QR код</a> 572 </div> 573 574 575 </div> 576 577<ul id="tabs"> 578 <li id="tab-button1"><a href="#" atitle="tab1">ÐнноÑаÑиÑ</a></li> 579 <li id="tab-button2"><a href="#" atitle="tab2">Ðб авÑоÑÐ°Ñ </a></li> 580 <li id="tab-button3"><a href="#" atitle="tab3">СпиÑок лиÑеÑаÑÑÑÑ</a></li> 581 <li id="tab-button6" style="display: none"><a href="#" atitle="tab6">Cited By</a></li> 582 <li id="tab-button8" style="display: none"><a href="#" atitle="tab8">Scopus Cited</a></li> 583 </ul> 584<div id="tab-holder"> 585 <div id="tab1" class="tab-wrap"> 586 <div id="articleAbstract"> 587 <h3>ÐнноÑаÑиÑ</h3> 588 <div><p>Ð¦ÐµÐ»Ñ Ð½Ð°ÑÑоÑÑей пÑбликаÑии â пÑодемонÑÑÑиÑоваÑÑ ÑÑÑекÑивноÑÑÑ Ð¿ÑÐ¸Ð¼ÐµÐ½ÐµÐ½Ð¸Ñ ÑиÑзепаÑида Ñ Ð¿Ð°ÑиенÑа Ñ Ð¾Ð¶Ð¸Ñением и аÑÑоÑииÑованнÑми комоÑбиднÑми ÑоÑÑоÑниÑми в ÑÑловиÑÑ ÑеалÑной клиниÑеÑкой пÑакÑики. ÐÑедÑÑавлено клиниÑеÑкое наблÑдение паÑиенÑа 36 Ð»ÐµÑ Ñ Ð¾Ð¶Ð¸Ñением II ÑÑепени, аÑÑеÑиалÑной гипеÑÑензией, наÑÑÑенной ÑолеÑанÑноÑÑÑÑ Ðº глÑкозе, гипеÑлипидемией, гипеÑÑÑикемией и меÑаболиÑеÑки аÑÑоÑииÑованной жиÑовой болезнÑÑ Ð¿ÐµÑени. ÐÑÑ Ð¾Ð´Ð½Ð¾ маÑÑа Ñела паÑиенÑа ÑоÑÑавлÑла 126 кг, Ð¸Ð½Ð´ÐµÐºÑ Ð¼Ð°ÑÑÑ Ñела â 38 кг/м2, окÑÑжноÑÑÑ Ñалии â 117 Ñм. ÐаÑиенÑÑ Ð±Ñли ÑÐµÐºÐ¾Ð¼ÐµÐ½Ð´Ð¾Ð²Ð°Ð½Ñ Ð¼Ð¾Ð´Ð¸ÑикаÑÐ¸Ñ Ð¾Ð±Ñаза жизни и ÑеÑÐ°Ð¿Ð¸Ñ ÑиÑзепаÑидом Ñ Ð¿Ð¾ÑÑепенной ÑиÑÑаÑией Ð´Ð¾Ð·Ñ Ð´Ð¾ 12,5 мг 1 Ñаз в неделÑ. ЧеÑез 15 меÑ. ÑеÑапии маÑÑа Ñела ÑнизилаÑÑ Ð´Ð¾ 91 кг (-27,8%), Ð¸Ð½Ð´ÐµÐºÑ Ð¼Ð°ÑÑÑ Ñела â до 27,8 кг/м2, окÑÑжноÑÑÑ Ñалии â до 94 Ñм. ÐÑмеÑено ÑлÑÑÑение композиÑионного ÑоÑÑава Ñела в виде ÑменÑÑÐµÐ½Ð¸Ñ Ð¼Ð°ÑÑÑ Ð¶Ð¸Ñовой Ñкани пÑи ÑÐ¾Ñ Ñанении мÑÑеÑного компоненÑа. Ðа Ñоне леÑÐµÐ½Ð¸Ñ Ð´Ð¾ÑÑигнÑÑа ноÑмализаÑÐ¸Ñ Ð¿Ð¾ÐºÐ°Ð·Ð°Ñелей Ñглеводного обмена, липидного пÑоÑилÑ, ÑÑÐ¾Ð²Ð½Ñ Ð¼Ð¾Ñевой киÑлоÑÑ Ð¸ аÑÑеÑиалÑного давлениÑ. Ðо даннÑм ÑÑ Ð¾ÐºÐ°ÑдиогÑаÑии оÑмеÑалоÑÑ ÑменÑÑение ÑолÑÐ¸Ð½Ñ ÑпикаÑдиалÑной жиÑовой Ñкани. ÐлиниÑеÑки знаÑимÑÑ Ð½ÐµÐ¶ÐµÐ»Ð°ÑелÑнÑÑ Ñвлений на пÑоÑÑжении пеÑиода наблÑÐ´ÐµÐ½Ð¸Ñ Ð·Ð°ÑегиÑÑÑиÑовано не бÑло. ТиÑзепаÑид ÑвлÑеÑÑÑ Ð¿ÐµÑÑпекÑивнÑм ÑеÑапевÑиÑеÑким инÑÑÑÑменÑом Ð´Ð»Ñ Ð»ÐµÑÐµÐ½Ð¸Ñ Ð¾Ð¶Ð¸ÑÐµÐ½Ð¸Ñ Ñ Ð¿Ð°ÑиенÑов Ñ ÐºÐ°ÑдиомеÑаболиÑеÑкими наÑÑÑениÑми. Ð ÑÑловиÑÑ ÑеалÑной пÑакÑики пÑименение пÑепаÑаÑа позволÑÐµÑ Ð´Ð¾ÑÑигаÑÑ Ð²ÑÑаженного ÑÐ½Ð¸Ð¶ÐµÐ½Ð¸Ñ Ð¼Ð°ÑÑÑ Ñела, ÑопÑовождаÑÑегоÑÑ Ð±Ð»Ð°Ð³Ð¾Ð¿ÑиÑÑной динамикой показаÑелей Ñглеводного, липидного и пÑÑинового обмена, а Ñакже Ñнижением ÑеÑдеÑно-ÑоÑÑдиÑÑого ÑиÑка. ÐÑобÑй инÑеÑÐµÑ Ð¿ÑедÑÑавлÑÐµÑ Ð²Ð¾Ð·Ð¼Ð¾Ð¶Ð½Ð¾ÑÑÑ ÑменÑÑÐµÐ½Ð¸Ñ Ð¶Ð¸Ñового компоненÑа маÑÑÑ Ñела пÑи ÑÐ¾Ñ Ñанении мÑÑеÑной Ñкани. ХоÑоÑÐ°Ñ Ð¿ÐµÑеноÑимоÑÑÑ ÑеÑапии и оÑÑÑÑÑÑвие знаÑимÑÑ Ð½ÐµÐ¶ÐµÐ»Ð°ÑелÑнÑÑ Ñвлений подÑвеÑждаÑÑ Ð²ÑÑокий ÑеÑапевÑиÑеÑкий поÑенÑиал ÑиÑзепаÑида Ñ Ð¿Ð°ÑиенÑов Ñ Ð¾ÑложненнÑм ожиÑением и комоÑбидной паÑологией.</p></div> 589 </div> 590 <div id="articleSubject"> 591 <h3>ÐлÑÑевÑе Ñлова</h3> 592 <div> 593 594 <a rel="nofollow" href="/index.php/jour/search/?subject=ожиÑение">ожиÑение</a>, 595 <a rel="nofollow" href="/index.php/jour/search/?subject= аÑÑеÑиалÑÐ½Ð°Ñ Ð³Ð¸Ð¿ÐµÑÑензиÑ"> аÑÑеÑиалÑÐ½Ð°Ñ Ð³Ð¸Ð¿ÐµÑÑензиÑ</a>, 596 <a rel="nofollow" href="/index.php/jour/search/?subject= диÑлипидемиÑ"> диÑлипидемиÑ</a>, 597 <a rel="nofollow" href="/index.php/jour/search/?subject= ÑеÑдеÑно-ÑоÑÑдиÑÑÑе ÑакÑоÑÑ ÑиÑка"> ÑеÑдеÑно-ÑоÑÑдиÑÑÑе ÑакÑоÑÑ ÑиÑка</a>, 598 <a rel="nofollow" href="/index.php/jour/search/?subject= ÑпикаÑдиалÑÐ½Ð°Ñ Ð¶Ð¸ÑÐ¾Ð²Ð°Ñ ÑканÑ"> ÑпикаÑдиалÑÐ½Ð°Ñ Ð¶Ð¸ÑÐ¾Ð²Ð°Ñ ÑканÑ</a>, 599 <a rel="nofollow" href="/index.php/jour/search/?subject= гипеÑÑÑикемиÑ"> гипеÑÑÑикемиÑ</a>, 600 <a rel="nofollow" href="/index.php/jour/search/?subject= инкÑеÑинÑ"> инкÑеÑинÑ</a>, 601 <a rel="nofollow" href="/index.php/jour/search/?subject= ÑиÑзепаÑид"> ÑиÑзепаÑид</a>, 602 <a rel="nofollow" href="/index.php/jour/search/?subject= клиниÑеÑкий ÑлÑÑай"> клиниÑеÑкий ÑлÑÑай</a> </div> 603 <br /> 604 </div> 605 606 607 </div> 608 <div id="tab2" class="tab-wrap"> 609 <h3 class="blockTitle"> 610 Ðб авÑоÑÐ°Ñ 611 </h3> 612 <a rel="nofollow" href='/index.php/jour/search?authors=Ð. Ð. Ð¡Ð°Ñ Ð½Ð¾Ð²Ð°'> 613 <em><strong>Ð. Ð. Ð¡Ð°Ñ Ð½Ð¾Ð²Ð°</strong></em> 614 </a><br /> 615 <div class="stepleft"> 616 РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; 617ÐÐР«СкандинавÑкий ЦенÑÑ ÐдоÑовÑÑ» 618 <br/>РоÑÑÐ¸Ñ 619 <br/><span><p><strong>Ð¡Ð°Ñ Ð½Ð¾Ð²Ð° ÐкаÑеÑина ÐвгенÑевна, </strong>ÑоиÑкаÑÐµÐ»Ñ ÐºÐ°ÑедÑÑ ÑеÑапии и полимоÑбидной паÑологии имени академика Ð.С. ÐовÑи, РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; вÑаÑÑндокÑинолог, ÐÐР«СкандинавÑкий ЦенÑÑ ÐдоÑовÑÑ»</p><p><em>125993, ÐоÑква, Ñл. ÐаÑÑикаднаÑ, д. 2/1, ÑÑÑ. 1,</em></p><p><em>
619111024, ÐоÑква, Ñл. 2-Ñ ÐабелÑнаÑ, д. 2, ÑÑÑ. 25, 26, 37</em></p><p> </p></span> 620 </div> 621 <div class="separator"></div> 622 <br/><br/> 623 624 <a rel="nofollow" href='/index.php/jour/search?authors=Ð. Ð. ÐавÑилова'> 625 <em><strong>Ð. Ð. ÐавÑилова</strong></em> 626 </a><br /> 627 <div class="stepleft"> 628 РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; 629ÐÐР«СкандинавÑкий ЦенÑÑ ÐдоÑовÑÑ» 630 <br/>РоÑÑÐ¸Ñ 631 <br/><span><p><strong>ÐавÑилова ÐаÑалÑÑ ÐвгенÑевна, </strong>д.м.н., пÑоÑеÑÑÐ¾Ñ ÐºÐ°ÑедÑÑ ÑеÑапии и полимоÑбидной паÑологии имени академика Ð.С. ÐовÑи, РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; генеÑалÑнÑй диÑекÑоÑ, главнÑй вÑаÑ, ÐÐР«СкандинавÑкий ЦенÑÑ ÐдоÑовÑÑ»</p><p><em>125993, ÐоÑква, Ñл. ÐаÑÑикаднаÑ, д. 2/1, ÑÑÑ. 1,</em></p><p><em>111024, ÐоÑква, Ñл. 2-Ñ ÐабелÑнаÑ, д. 2, ÑÑÑ. 25, 26, 37</em></p><p> </p></span> 632 </div> 633 <div class="separator"></div> 634 <br/><br/> 635 636 <a rel="nofollow" href='/index.php/jour/search?authors=Ð. Ð. ÐÑÑÑоÑмова'> 637 <em><strong>Ð. Ð. ÐÑÑÑоÑмова</strong></em> 638 </a><br /> 639 <div class="stepleft"> 640 РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; 641ÐеÑвÑй ÐоÑковÑкий гоÑÑдаÑÑÑвеннÑй медиÑинÑкий ÑнивеÑÑиÑÐµÑ Ð¸Ð¼ÐµÐ½Ð¸ Ð.Ð. СеÑенова (СеÑеновÑкий УнивеÑÑиÑеÑ) 642 <br/>РоÑÑÐ¸Ñ 643 <br/><span><p><strong>ÐÑÑÑоÑмова</strong><strong> </strong><strong>ÐлÑга</strong><strong> </strong><strong>ÐмиÑÑиевна,</strong><strong> </strong>д.м.н., пÑоÑеÑÑоÑ, заведÑÑÑÐ°Ñ ÐºÐ°ÑедÑой ÑеÑапии и полимоÑбидной паÑологии имени академика Ð.С. ÐовÑи, РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; пÑоÑеÑÑÐ¾Ñ ÐºÐ°ÑедÑÑ ÐºÐ»Ð¸Ð½Ð¸ÑеÑкой ÑаÑмакологии и пÑопедевÑики внÑÑÑÐµÐ½Ð½Ð¸Ñ Ð±Ð¾Ð»ÐµÐ·Ð½ÐµÐ¹, ÐеÑвÑй ÐоÑковÑкий гоÑÑдаÑÑÑвеннÑй медиÑинÑкий ÑнивеÑÑиÑÐµÑ Ð¸Ð¼ÐµÐ½Ð¸ Ð.Ð. СеÑенова (СеÑеновÑкий УнивеÑÑиÑеÑ);</p><p><em>125993, ÐоÑква, Ñл. ÐаÑÑикаднаÑ, д. 2/1, ÑÑÑ. 1,</em></p><p>119048, ÐоÑква, Ñл. ТÑÑбеÑкаÑ, д. 8, ÑÑÑ. 2</p></span> 644 </div> 645 <div class="separator"></div> 646 <br/><br/> 647 648 <a rel="nofollow" href='/index.php/jour/search?authors=Ð. Ð. ÐоÑеÑков'> 649 <em><strong>Ð. Ð. ÐоÑеÑков</strong></em> 650 </a><br /> 651 <div class="stepleft"> 652 РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑÐ°Ð·Ð¾Ð²Ð°Ð½Ð¸Ñ 653 <br/>РоÑÑÐ¸Ñ 654 <br/><span><p><strong>ÐоÑеÑков ÐлекÑей ÐвановиÑ, </strong>к.м.н., доÑенÑ, доÑÐµÐ½Ñ ÐºÐ°ÑедÑÑ ÑеÑапии и полимоÑбидной паÑологии имени академика Ð.С. ÐовÑи</p><p><em>125993, ÐоÑква, Ñл. ÐаÑÑикаднаÑ, д. 2/1, ÑÑÑ. 1</em></p><p> </p></span> 655 </div> 656 <div class="separator"></div> 657 <br/><br/> 658 659 <a rel="nofollow" href='/index.php/jour/search?authors=С. С. Телкова'> 660 <em><strong>С. С. Телкова</strong></em> 661 </a><br /> 662 <div class="stepleft"> 663 РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑÐ°Ð·Ð¾Ð²Ð°Ð½Ð¸Ñ 664 <br/>РоÑÑÐ¸Ñ 665 <br/><span><p><strong>Телкова СвеÑлана СеÑгеевна, </strong>аÑÑиÑÑенÑ, ÑÑаÑÑий лабоÑанÑ, аÑпиÑÐ°Ð½Ñ ÐºÐ°ÑедÑÑ ÑеÑапии и полимоÑбидной паÑологии имени академика Ð.С. ÐовÑи</p><p><em>125993, ÐоÑква, Ñл. ÐаÑÑикаднаÑ, д. 2/1, ÑÑÑ. 1</em></p></span> 666 </div> 667 <div class="separator"></div> 668 <br/><br/> 669 670 <a rel="nofollow" href='/index.php/jour/search?authors=Ю. С. ÐоÑÑкова'> 671 <em><strong>Ю. С. ÐоÑÑкова</strong></em> 672 </a><br /> 673 <div class="stepleft"> 674 РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; 675ÐÐР«СкандинавÑкий ЦенÑÑ ÐдоÑовÑÑ» 676 <br/>РоÑÑÐ¸Ñ 677 <br/><span><p><strong>ÐоÑÑкова</strong><strong> </strong><strong>Ð®Ð»Ð¸Ñ Ð¡ÑаниÑлавовна, </strong>ÑоиÑкаÑÐµÐ»Ñ ÐºÐ°ÑедÑÑ ÑеÑапии и полимоÑбидной паÑологии имени академика Ð.С. ÐовÑи, РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; вÑаÑ-каÑдиолог, ÐÐР«СкандинавÑкий ЦенÑÑ ÐдоÑовÑÑ»</p><p><em>125993, ÐоÑква, Ñл. ÐаÑÑикаднаÑ, д. 2/1, ÑÑÑ. 1,</em></p><p><em>
677111024, ÐоÑква, Ñл. 2-Ñ ÐабелÑнаÑ, д. 2, ÑÑÑ. 25, 26, 37</em></p></span> 678 </div> 679 <div class="separator"></div> 680 <br/><br/> 681 682 683 </div> 684 <div id="tab3" class="tab-wrap"> 685 <h3>СпиÑок лиÑеÑаÑÑÑÑ</h3> 686 <div id="articleCitations"> 687 <div> 688 <p><span class ="citation-number">1. </span>Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13(3):221â262. https://doi.org/10.1016/S2213-8587(24)00316-4.</p> 689 <p><span class ="citation-number">2. </span>Fitch AK, Bays HE. Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obes Pillars. 2022;1:100004. https://doi.org/10.1016/j.obpill.2021.100004.</p> 690 <p><span class ="citation-number">3. </span>Ðедов ÐÐ, ÐокÑÑÑева ÐÐ, ÐелÑниÑенко ÐÐ, ТÑоÑина ÐÐ, ÐазÑÑина ÐÐ, ÐÑÑова ÐРи дÑ. ÐлиниÑеÑкие ÑекомендаÑии «ÐжиÑение» ÐинздÑава РоÑÑии. ÐеÑÑÐ¸Ñ 2024 года. ÐеÑÑник ÑепÑодÑкÑивного здоÑовÑÑ. 2025;4(2):14â30. https://doi.org/10.14341/brh12763.</p> 691 <p><span class ="citation-number">4. </span>Ðаланова ЮÐ, ШалÑнова СÐ, Ðмаева ÐÐ, ÐÑÑенко ÐÐ, ÐапÑÑÑина ÐÐ, ÐÑÑомÑева ÐРи дÑ. ÐжиÑение в ÑоÑÑийÑкой попÑлÑÑии: вклад в вÑживаемоÑÑÑ Ð¸ возникновение ÑеÑдеÑно-ÑоÑÑдиÑÑÑÑ ÑобÑÑий. ÐаннÑе иÑÑледований ÐССÐ-РФ и ÐССÐ-РФ2. ÐаÑдиоваÑкÑлÑÑÐ½Ð°Ñ ÑеÑÐ°Ð¿Ð¸Ñ Ð¸ пÑоÑилакÑика. 2025;24(6):4336. https://doi.org/10.15829/1728-8800-2025-4336.</p> 692 <p><span class ="citation-number">5. </span>Yanovski SZ, Yanovski JA. Approach to Obesity Treatment in Primary Care: A Review. JAMA Intern Med. 2024;184(7):818â829. https://doi.org/10.1001/jamainternmed.2023.8526.</p> 693 <p><span class ="citation-number">6. </span>Sumithran P, Proietto J. The defence of body weight: a physiological basis for weight regain after weight loss. Clin Sci. 2013;124(4):231â241. https://doi.org/10.1042/CS20120223.</p> 694 <p><span class ="citation-number">7. </span>Nadolsky K, Garvey WT, Agarwal M, Bonnecaze A, Burguera B, Chaplin MD et al. American Association of Clinical Endocrinology Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity--Based Chronic Disease â 2025 Update. Endocr Pract. 2025;31(11):1351â1394. https://doi.org/10.1016/j.eprac.2025.07.017.</p> 695 <p><span class ="citation-number">8. </span>Jastreboff AM, le Roux CW, Stefanski A, Aronne LG, Halpern B, Wharton S et al. Tirzepatide for Obesity Treatment and Diabetes Prevention. N Engl J Med. 2025;392(10):958â971. https://doi.org/10.1056/NEJMoa2410819.</p> 696 <p><span class ="citation-number">9. </span>Saha B, Kamalumpundi V, Codipilly DC. GLP1 and GIP Receptor Agonists: Effects on the Gastrointestinal Tract and Management Strategies for Primary Care Physicians. Mayo Clin Proc. 2025;100(12):2228â2236. https://doi.org/10.1016/j.mayocp.2025.09.017.</p> 697 <p><span class ="citation-number">10. </span>Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF. Lingvay I et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989â1002. https://doi.org/10.1056/nejmoa2032183.</p> 698 <p><span class ="citation-number">11. </span>Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205â216. https://doi.org/10.1056/nejmoa2206038.</p> 699 <p><span class ="citation-number">12. </span>Forzano I, Varzideh F, Avvisato R, Jankauskas SS, Mone P, Santulli G. Tirzepatide: A Systematic Update. Int J Mol Sci. 2022;23(23):14631. https://doi.org/10.3390/ijms232314631.</p> 700 <p><span class ="citation-number">13. </span>
700Hamza M, Papamargaritis D, Davies MJ. Tirzepatide for overweight and obesity management. Expert Opin Pharmacother. 2025;26(1):31â49. https://doi.org/10.1080/14656566.2024.2436595.</p> 701 <p><span class ="citation-number">14. </span>Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon LB, Valderas EG et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. N Engl J Med. 2025;393(1):26â36. https://doi.org/10.1056/NEJMoa2416394.</p> 702 <p><span class ="citation-number">15. </span>Rosenstock J, Wysham C, FrÃas JP, Kaneko S, Lee CJ, Fernández Landó L et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. Lancet. 2021;398(10295):143â155. https://doi.org/10.1016/S0140-6736(21)01324-6.</p> 703 <p><span class ="citation-number">16. </span>FrÃas JP, Davies MJ, Rosenstock J, Pérez Manghi FC, Fernández Landó L, Bergman BK et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021;385(6):503â515. https://doi.org/10.1056/NEJMoa2107519.</p> 704 <p><span class ="citation-number">17. </span>Ludvik B, Giorgino F, Jódar E, Frias JP, Fernández Landó L, Brown K et al. Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. Lancet. 2021;398(10300):583â598. https://doi.org/10.1016/S0140-6736(21)01443-4.</p> 705 <p><span class ="citation-number">18. </span>Del Prato S, Kahn SE, Pavo I, Weerakkody GJ, Yang Z, Doupis J et al. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial. Lancet. 2021;398(10313):1811â1824. https://doi.org/10.1016/S0140-6736(21)02188-7.</p> 706 <p><span class ="citation-number">19. </span>Dahl D, Onishi Y, Norwood P, Huh R, Bray R, Patel H, RodrÃguez Ã. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial. JAMA. 2022;327(6):534â545. https://doi.org/10.1001/jama.2022.0078.</p> 707 <p><span class ="citation-number">20. </span>Rosenstock J, FrÃas JP, Rodbard HW, Tofé S, Sears E, Huh R et al. Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial. JAMA. 2023;330(17):1631â1640. https://doi.org/10.1001/jama.2023.20294.</p> 708 <p><span class ="citation-number">21. </span>Garvey WT, Frias JP, Jastreboff AM, le Roux С, Sattar N, Aizenberg D et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2023;402(10402):613â626. https://doi.org/10.1016/S0140-6736(23)01200-X.</p> 709 <p><span class ="citation-number">22. </span>Wadden TA, Chao AM, Machineni S, Kushner R, Ard J, Srivastava G et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. Nat Med. 2024;30(6):1784. https://doi.org/10.1038/s41591-024-02883-1.</p> 710 <p><span class ="citation-number">23. </span>Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin WY et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024;331(1):38â48. https://doi.org/10.1001/jama.2023.24945.</p> 711 <p><span class ="citation-number">24. </span>Sinha R, Papamargaritis D, Sargeant JA, Davies MJ. Efficacy and
711Safety of Tirzepatide in Type 2 Diabetes and Obesity Management. J Obes Metab Syndr. 2023;32(1):25â45. https://doi.org/10.7570/jomes22067.</p> 712 <p><span class ="citation-number">25. </span>Sattar N, GarcÃa-Pérez L-E, RodrÃguez A, Kapoor R, Stefanski A, Hankosky ER. Tirzepatide and cardiometabolic parameters in obesity: Summary of current evidence. Diabetes Obes Metab. 2025;27(10):5386â5392. https://doi.org/10.1111/dom.16549.</p> 713 <p><span class ="citation-number">26. </span>McGowan B, Ciudin A, Baker JL, Busetto L, Dicker D, Frühbeck G et al. Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO). Nat Med. 2025;31(10):3229â3232. https://doi.org/10.1038/s41591-025-03765-w.</p> 714 <p><span class ="citation-number">27. </span>Elmaleh-Sachs A, Schwartz JL, Bramante CT, Nicklas JM, Gudzune KA, Jay M. Obesity Management in Adults: A Review. JAMA. 2023;330(20):2000â2015. https://doi.org/10.1001/jama.2023.19897.</p> 715 <p><span class ="citation-number">28. </span>ШеÑÑакова ÐÐ, ÐаÑлÑкова Ð Ð. ÐеÑÑпекÑÐ¸Ð²Ñ Ð»ÐµÑÐµÐ½Ð¸Ñ ÑÐ°Ñ Ð°Ñного диабеÑа 2-го Ñипа и ожиÑениÑ: наÑÑоÑÑее и бÑдÑÑее инкÑеÑиноÑеÑапии. ТеÑапевÑиÑеÑкий аÑÑ Ð¸Ð². 2025;97(10):823â829. https://doi.org/10.26442/00403660.2025.10.203366.</p> 716 <p><span class ="citation-number">29. </span>Liu S, Hu J, Zhao C, Liu H, He C. Comparative efficacy of incretin drugs on glycemic control, body weight, and blood pressure in adults with overweight or obesity and with/without type 2 diabetes: a systematic review and network meta-analysis. Front Endocrinol. 2025;16:1513641. https://doi.org/10.3389/fendo.2025.1513641.</p> 717 <p><span class ="citation-number">30. </span>Koskinas KC, Van Craenenbroeck EM, Antoniades C, Blüher M, Gorter TM, Hanssen H et al. Obesity and cardiovascular disease: an ESC clinical consensus statement. Eur J Prev Cardiol. 2025;32(3):184â220. https://doi.org/10.1093/eurjpc/zwae279.</p> 718 <p><span class ="citation-number">31. </span>Krumholz HM, de Lemos JA, Sattar N, Linetzky B, Sharma Ð , Mast CJ et al. Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial. Heart. 2024;110(19):1165â1171. https://doi.org/10.1136/heartjnl-2024-324170.</p> 719 <p><span class ="citation-number">32. </span>de Lemos JA, Linetzky B, le Roux CW, Laffin LJ, Vongpatanasin W, Fan L et al. Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index â¥27 kg/m(2): SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy. Hypertension. 2024;81(4):e41âe43. https://doi.org/10.1161/HYPERTENSIONAHA.123.22022.</p> 720 <p><span class ="citation-number">33. </span>Kanbay M, Copur S, Siriopol D, Yildiz AB, Gaipov A, van Raalte DH, Tuttle KR. Effect of tirzepatide on blood pressure and lipids: A meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2023;25(12):3766â3778. https://doi.org/10.1111/dom.15272.</p> 721 <p><span class ="citation-number">34. </span>Carraro-Lacroix LR, Malnic G, Girardi ACC. Regulation of Na+ /H+ exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells. Am J Physiol Renal Physiol. 2009;297(6):F1647âF1655. https://doi.org/10.1152/ajprenal.00082.2009.</p> 722 <p><span class ="citation-number">35. </span>Cho YK, La Lee Y, Jung CH. The Cardiovascular Effect of Tirzepatide: A Gluc
722agon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist. J Lipid Atheroscler. 2023;12(3):213â222. https://doi.org/10.12997/jla.2023.12.3.213.</p> 723 <p><span class ="citation-number">36. </span>Linetzky B, See SK, Zhang X, Stefanski Ð, Wilson J, Ruotolo G. Body weight reduction-associated and -unassociated changes in lipid profile in people with obesity, with or without T2D, treated with tirzepatide: post-hoc analysis of SURMOUNT-1 and SURMOUNT-2. Circulation. 2024;150(Suppl. 1):4141358. https://doi.org/10.1161/circ.150.suppl_1.4141358.</p> 724 <p><span class ="citation-number">37. </span>Angelopoulos N, Livadas S, Androulakis I, Petkova, V, Rizoulis A, Boniakos A et al. Short-term effects of low-dose tirzepatide on lipid profile, glucose homeostasis and hepatic steatosis index in adults with obesity, but without diabetes mellitus: a prospective observational study. J Diabetes Complications. 2025;39(12):109181. https://doi.org/10.1016/j.jdiacomp.2025.109181.</p> 725 <p><span class ="citation-number">38. </span>Xie F, Zhang W. Effects of tirzepatide on lipid profiles in type 2 diabetes mellitus A meta-analysis. Clin Focus. 2025;40(12):1061â1067. https://doi.org/10.3969/j.issn.1004-583X.2025.12.001.</p> 726 <p><span class ="citation-number">39. </span>Mahar MU, Mahmud O, Ahmed S, Qureshi SA, Kakar WG, Fatima SS. The Effects of Tirzepatide on Lipid Profile: A Systematic Review and MetaAnalysis of Randomized Controlled Trials. J Obes Metab Syndr. 2024;33(4):348â359. https://doi.org/10.7570/jomes24008.</p> 727 <p><span class ="citation-number">40. </span>Feingold KR. Obesity and Dyslipidemia. In: Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G et al. (eds.). Endotext. South Dartmouth (MA): MDText.com, Inc.; 2026. Available at: https://www.ncbi.nlm.nih.gov/books/NBK305895/.</p> 728 <p><span class ="citation-number">41. </span>Bu T, Sun Z, Pan Y, Deng X, Yuan G. Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism. Diabetes Metab J. 2024;48(3):354â372. https://doi.org/10.4093/dmj.2023.0277.</p> 729 <p><span class ="citation-number">42. </span>Sachs S, Götz A, Finan B, Feuchtinger Ð, DiMarchi RD, Döring Y et al. GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardiometabolic disease. Cardiovasc Diabetol. 2023;22(1):217. https://doi.org/10.1186/s12933-023-01940-2.</p> 730 <p><span class ="citation-number">43. </span>Wilson JM, Nikooienejad A, Robins DA, Roell WC, Riesmeyer JS, Haupt A et al. The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes. Diabetes Obes Metab. 2020;22(12):2451â2459. https://doi.org/10.1111/dom.14174.</p> 731 <p><span class ="citation-number">44. </span>Gastaldelli A, Cusi K, Fernández Landó L, Bray R, Brouwers B, RodrÃguez Ã. Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial. Lancet Diabetes Endocrinol. 2022;10(6):393â406. https://doi.org/10.1016/S2213-8587(22)00070-5.</p> 732 <p><span class ="citation-number">45. </span>Sattar N, Scilletta S, Stefanski A, Wang H, Daly JW, Linetzky B. Tirzepatide and change in uric acid and its association with weight reduction: post hoc analyses of the SURMOUNT-1 randomised placebo-controlled trial. Ann Rheum Dis. 2026;85(3):558â565. https://doi.org/10.1016/j.ard.2025.10.009.</p> 733 <p><span class ="citation-number">46. </span>Mandal AK, Leask MP, Estiverne C, Choi HK, Merriman TR, Mount DB. Genetic and Physiological Effects of Insulin on Human Urate Homeostasis. Front Physiol. 2021;12:713710. https://doi.org/10.3389/fphys.2021.713710.</p> 734 <p><span class ="citation-number">47. </span>Xu L, Shi Y, Zhuang S, Liu N. Recent advances on uric acid transporters. Oncotarget. 2017;8(59):100852â100862. https://doi.org/10.18632/oncotarget.20135.</p> 735 <p><span class ="citation-number">48. </span>Tonneijck L, Muskiet MHA, Smits MM, Bjornstad P, Kramer MHH, Diamant M et al. Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trials. Diabetes Obes Metab. 2018;20(5):1235â1245. https://doi.org/10.1111/dom.13223.</p> 736 <p><span class ="citation-number">49. </span>Mather KJ, Coskun T, Pratt EJ, Milicevic Z, Weerakkody G, Thomas MK et al. Improvements in post-challenge lipid response following tirzepatide treatment in patients with type 2 diabetes. Diabetes Obes Metab. 2024;26(2):785â789. https://doi.org/10.1111/dom.15365.</p> 737 <p><span class ="citation-number">50. </span>Wilson JM, Lin Y, Luo MJ, Considine G, Cox ÐL, Bowsman LM et al. The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A post hoc analysis. Diabetes Obes Metab. 2022;24(1):148â153. https://doi.org/10.1111/dom.14553.</p> 738 <p><span class ="citation-number">51. </span>Borlaug BA, Zile MR, Kramer CM, Baum SJ, Hurt K, Litwin SE et al. Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial. Nat Med. 2025;31(2):544â551. https://doi.org/10.1038/s41591-024-03374-z.</p> 739 <p><span class ="citation-number">52. </span>Iacobellis G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol. 2022;19(9):593â606. https://doi.org/10.1038/s41569-022-00679-9.</p> 740 <p><span class ="citation-number">
74053. </span>Li C, Liu X, Adhikari BK, Chen L, Liu W, Wang Y, Zhang H. The role of epicardial adipose tissue dysfunction in cardiovascular diseases: an overview of pathophysiology, evaluation, and management. Front Endocrinol. 2023;14:1167952. https://doi.org/10.3389/fendo.2023.1167952.</p> 741 <p><span class ="citation-number">54. </span>Packer M. Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium. J Am Coll Cardiol. 2018;71(20):2360â2372. https://doi.org/10.1016/j.jacc.2018.03.509.</p> 742 <p><span class ="citation-number">55. </span>Wiszniewski K, Grudniewska A, SzabÅowska-Gadomska I, Pilichowska-Paszkiet E, Zaborska B, ZgliczyÅski W et al. Epicardial Adipose Tissue â A Novel Therapeutic Target in Obesity Cardiomyopathy. Int J Mol Sci. 2025;26(16):7963. https://doi.org/10.3390/ijms26167963.</p> 743 <p><span class ="citation-number">56. </span>Dozio E, Vianello E, Malavazos AE, Tacchini L, Schmitz G, Iacobellis G, Corsi Romanelli MM. Epicardial adipose tissue GLP-1 receptor is associated with genes involved in fatty acid oxidation and white-to-brown fat differentiation: A target to modulate cardiovascular risk? Int J Cardiol. 2019;292:218â224. https://doi.org/10.1016/j.ijcard.2019.04.039.</p> 744 <p><span class ="citation-number">57. </span>Gustafsson B, Rovio SP, Ruohonen S, Kähönen NH, Kähönen M, Viikari JSA et al. Determinants of echocardiographic epicardial adipose tissue in a general middle aged population â The Cardiovascular Risk in Young Finns Study. Sci Rep. 2024;14(1):11982. https://doi.org/10.1038/s41598-024-61727-7.</p> 745 <p><span class ="citation-number">58. </span>Kramer CM, Borlaug BA, Zile MR, Ruff D, DiMaria JM, Menon V et al. Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR Substudy. J Am Coll Cardiol. 2025;85(7):699â706. https://doi.org/10.1016/j.jacc.2024.11.001.</p> 746 <p><span class ="citation-number">59. </span>Packer M, Zile MR, Kramer CM, Baum SJ, Litwin SE, Menon V et al. Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity. N Engl J Med. 2025;392(5):427â437. https://doi.org/10.1056/NEJMoa2410027.</p> 747 <p><span class ="citation-number">60. </span>Malavazos AE, Iacobellis G, Dozio E, Basilico S, Di Vincenzo A, Dubini C et al. Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies. Eur J Prev Cardiol. 2023;30(8):680â693. https://doi.org/10.1093/eurjpc/zwad050.</p> 748 749 </div> 750 <br /> 751 </div> 752 753 754 </div> 755 756 <div id="tab6" class="tab-wrap"></div> 757 758 <div id="tab8" class="tab-wrap"></div> 759 760 <div id="tab7" class="tab-wrap"> 761 <h3>РеÑензиÑ</h3> 762 <div class="reviewText"> 763 764 </div> 765 </div> 766</div> 767 768 769 770<div class="reference"> 771 772 <h4 class="tocSectionTitle">ÐÐ»Ñ ÑиÑиÑованиÑ:</h4><hr/> 773 774 775 <p id="citRus"> 776 Ð¡Ð°Ñ Ð½Ð¾Ð²Ð° ÐÐ, 777 ÐавÑилова ÐÐ, 778 ÐÑÑÑоÑмова ÐÐ, 779 ÐоÑеÑков ÐÐ, 780 Телкова СС, 781 ÐоÑÑкова ЮС. 782 ÐÑÑекÑивноÑÑÑ Ð¸ безопаÑноÑÑÑ ÑиÑзепаÑида в леÑении ожиÑÐµÐ½Ð¸Ñ Ð¸ аÑÑоÑииÑованнÑÑ Ñ Ð½Ð¸Ð¼ комоÑбиднÑÑ ÑоÑÑоÑний. <i>ÐедиÑинÑкий СовеÑ</i>. 2026;(13):15-26. <a href="https://doi.org/10.21518/ms2026-324" target="_blank">https://doi.org/10.21518/ms2026-324</a> 783 </p> 784 785 786 <h4 class="tocSectionTitle">For citation:</h4><hr/> 787 <p id="citEng"> Sakhnova EE, 788 Gavrilova NE, 789 Ostroumova OD, 790 Kochetkov ÐI, 791 Telkova SS, 792 Moryakova YS. 793 Efficacy and safety of tirzepatide in the treatment of obesity and obesity-associated comorbidities. <i>Meditsinskiy sovet = Medical Council</i>. 2026;(13):15-26. 794 (In Russ.) 795 796 <a href="https://doi.org/10.21518/ms2026-324" target="_blank">https://doi.org/10.21518/ms2026-324</a> 797 </p> 798 799</div> 800<div class="fullback" id="qr-back" > 801 <div class="image-wrapper"> 802 <div id="qrcode"></div> 803 <a class="close-cross" href="#" onclick="$('#qr-back').hide(); return false;"></a> 804 </div> 805</div> 806 807
808<script type="text/javascript"> 809 810function switchTab(tab){ 811 $("#tabs li a").each(function(){ 812 if (tab==$(this).attr("atitle")){ 813 jQuery("#tab-holder .tab-wrap").hide(); 814 jQuery("#tabs li").attr("id",""); 815 jQuery("#tabs a[atitle='"+tab+"']").parent().attr("id","current"); 816 jQuery('#' + tab).fadeIn(); 817 } 818 }) 819 820} 821 822jQuery(document).ready(function(){ 823 824 jQuery("#tab-holder .tab-wrap").hide(); // СкÑÑваем ÑодеÑжание 825 jQuery("#tabs li:first").attr("id","current"); // ÐкÑивиÑÑем пеÑвÑÑ Ð·Ð°ÐºÐ»Ð°Ð´ÐºÑ 826 jQuery("#tab-holder div:first").fadeIn(); // ÐÑводим ÑодеÑжание 827 828 jQuery('#tabs a, .tab-switcher').click(function(e) { 829 e.preventDefault(); 830 switchTab(jQuery(this).attr('atitle')); 831 }); 832 if($("#articleCitations div p").length>0){ 833 parseCitaions('#articleCitations div p'); 834 } 835 if ($('.fullHTML').length>0){ 836 HTMLhiglight=Autolinker.link( $('.fullHTML').html(), 837 { 838 'stripPrefix':false, 'phone': false, 839 replaceFn: function( autolinker, match ){ 840 if (match && match.getMatchedText().length<5) return false; 841 return; 842 } 843 }); 844 $('.fullHTML').html(HTMLhiglight); 845 } 846 847 if(window.location.hash){ 848 var hash = window.location.hash; 849 if($(hash).length){ 850 switchTab(hash.substring(1)); 851 window.scrollTo(0, 0); 852 setTimeout(function() { 853 $(window).scrollTop($(hash).offset().top); 854 }, 1); 855 return false; 856 } 857 } 858}); 859 860 </script>
860 861 862 <div class="views"> 863 864 ÐÑоÑмоÑÑов: 865 178 866 </div> 867 <br/><a target="_blank" href="https://www.med-sovet.pro/jour/article/jats/10423">JATS XML</a> 868 869 870<div id="ccLicense385"><br /><br /> 871<a target="_blank" rel="license" href="https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ru"> 872<img alt="Creative Commons License" style="border-width:0" src="/resources/by-nc-nd.eu.png" height="30px" /> 873</a> 874<br/> 875ÐонÑÐµÐ½Ñ Ð´Ð¾ÑÑÑпен под лиÑензией <a rel="license" target="_blank" href="https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ru">Creative Commons Attribution 4.0 License</a>.</div> 876 877 878 879
880<script type="text/javascript"> 881 882 883function createCitedBy(){ 884 var url = "https://www.med-sovet.pro/jour/article/citedBy/10423"; 885 $.get(url, function(data){ 886 if (!data || !data.length) return; 887 var html = '<div class="citedby">'; 888 html+= '<h2>Cited By</h2>'; 889 for (var i=0; i<data.length; i+=1){ 890 html+= '<div class="cite">'; 891 html+= '<p><span class="value title"><a target="_blank" rel="nofollow" href="'+data[i]["link"]+'"">'+data[i]["title"]+'</a></span></p>'; 892 html+= '<p><span class="value authors">'+data[i]["authors"]+'</span></p>'; 893 html+= '<span class="value journal">'; 894 if (data[i]["journal"]) html += data[i]["journal"]+', '; 895 if (data[i]["year"]) html += data[i]["year"]+'; '; 896 if (data[i]["volume"]) html += data[i]["volume"]; 897 if (data[i]["issue"]) html += '('+data[i]["issue"]+')'; 898 if (data[i]["first_page"]) html += ":"+data[i]["first_page"]; 899 html+= "</span></p>"; 900 html+= '<p><span class="value doi">DOI: <a target="_blank" rel="nofollow" href="'+data[i]["link"]+'"">'+data[i]["doi"]+'</a></span></p>'; 901 html+= '</div>'; 902 903 904 } 905 html += '</div>'; 906 $("#tab6").html(html); 907 $("#tab-button6 a").text("Cited By ("+data.length+")"); 908 $("#tab-button6").show(); 909 }); 910} 911 912function createScopusCitations(){ 913 var url = "https://www.med-sovet.pro/jour/article/scopusCitations/10423"; 914 $.get(url, function(data){ 915 if (!data || !data.length) return; 916 var html = '<div class="citedby">'; 917 html+= '<h2>Scopus Cited</h2>'; 918 for (var i=0; i<data.length; i+=1){ 919 html+= '<div class="cite">'; 920 html+= '<p><span class="value title"><a target="_blank" rel="nofollow" href="'+data[i]["link"]+'"">'+data[i]["title"]+'</a></span></p>'; 921 html+= '<p><span class="value authors">'+data[i]["authors"]+'</span></p>'; 922 html+= '<span class="value journal">'; 923 if (data[i]["journal"]) html += data[i]["journal"]+', '; 924 if (data[i]["year"]) html += data[i]["year"]+'; '; 925 if (data[i]["issue"]) html += data[i]["issue"]; 926 if (data[i]["volume"]) html += data[i]["volume"]; 927 if (data[i]["first_page"]) html += ":"+data[i]["first_page"]; 928 html+= ";</span></p>"; 929 html+= '<p><span class="value doi">DOI: <a target="_blank" rel="nofollow" href="'+data[i]["link"]+'"">'+data[i]["doi"]+'</a></span></p>'; 930 html+= '</div>'; 931 932 933 } 934 html += '</div>'; 935 $("#tab8").html(html); 936 $("#tab-button8 a").text("Scopus Cited ("+data.length+")"); 937 $("#tab-button8").show(); 938 }); 939} 940 941function createMetricChart(){ 942 var url = "https://www.med-sovet.pro/jour/article/metrics/10423"; 943 944 945 $.get(url, function(data){ 946 console.log(1); 947 var ctx = document.getElementById('metricChart'); 948 console.log(2); 949 if (!data || !data['months'].length) return; 950 var chart_data = { 951 labels: data['months'], 952 datasets: [{ 953 label: 'СÑаÑиÑÑика', 954 data: data['counts'], 955 fill: false, 956 borderColor: '#ffb400', 957 tension: 0.1 958 }] 959 }; 960 961 new Chart(ctx, { 962 type: "line", 963 data: chart_data 964 }); 965 }); 966} 967 968 969$(document).ready(function(){ 970 var doi = $("meta[name='DC.Identifier.DOI']").attr("content"); 971 if (!doi || doi=="undefined") {$("a.block-link").remove()} 972 if ($(".fullHTML").length) createCitationLinks(); 973 createCitedBy(); 974 createScopusCitations(); 975 /*createMetricChart();*/ 976 $('#qrcode-thumb').qrcode({width:25, height:25, text:window.location.href} ); 977 $('#qrcode').qrcode({width:150, height:150, background: "#f2f2f2", text:window.location.href} ); 978}); 979 980</script>
980 981
982<script src="/assets/js/author_highlight.js?v=24424"></script>
vendor: 1 bytes, line 982
982
983<script src="/assets/js/translit.js"></script>
vendor: 1 bytes, line 983
983
984<script src="/assets/js/qrcode.js"></script>
vendor: 1 bytes, line 984
984
985<script src="/assets/js/jquery.qrcode.js"></script>
985 986 987 988 989 990 991 <br /><br /> 992 <div id="pageFooter385">ISSN 2079-701X (Print)<br/>ISSN 2658-5790 (Online)<br/></div> 993 994<!-- Yandex.Metrika counter -->
995<script type="text/javascript"> 996 997(function(m,e,t,r,i,k,a){m[i]=m[i]||function(){(m[i].a=m[i].a||[]).push(arguments)}; 998 m[i].l=1*new Date(); 999 for (var j = 0; j < document.scripts.length; j++) {if (document.scripts[j].src === r) { return; }} 1000 k=e.createElement(t),a=e.getElementsByTagName(t)[0],k.async=1,k.src=r,a.parentNode.insertBefore(k,a)}) 1001 (window, document, "script", "https://mc.yandex.ru/metrika/tag.js", "ym"); 1002try { 1003 1004 1005ym(38092145, "init", {clickmap:true,trackLinks:true,accurateTrackBounce:true,webvisor:true}); 1006 1007 1008ym(37317640, "init", {clickmap:true,trackLinks:true,accurateTrackBounce:true,webvisor:true}); 1009ym(42558364, "init", {enableAll: true}); 1010} catch(e) { } 1011 1012</script>
1012 1013<!-- /Yandex.Metrika counter --> 1014</div> 1015</div> 1016 1017 <div id="sidebar" class="sidebar"> 1018 1019<div class="menu" id="sidebarMenu"> 1020 <ul> 1021 <li id="sidebar_submit"><a class="submitArticle" href="https://www.med-sovet.pro/jour/author/submit/1">ÐÑпÑавиÑÑ ÑÑаÑÑÑ</a></li> <li id="sidebar_author"><a href="https://www.med-sovet.pro/jour/about/submissions#authorGuidelines">ÐÑавила Ð´Ð»Ñ Ð°Ð²ÑоÑов</a></li> 1022 <li id="sidebar_editorialc"><a href="https://www.med-sovet.pro/jour/pages/view/EditorialC">РедакÑиÑ</a></li> 1023 <li id="sidebar_editorials" style="display:none"><a href="https://www.med-sovet.pro/jour/pages/view/EditorialS">РедакÑионнÑй ÑовеÑ</a></li> 1024 <li id="sidebar_policy"><a href="https://www.med-sovet.pro/jour/about/editorialPolicies#custom-0">РеÑензиÑование</a></li> 1025 <li id="sidebar_ethics"><a href="https://www.med-sovet.pro/jour/about/editorialPolicies#custom-1">ÐÑика пÑбликаÑий</a></li> 1026 </ul> 1027</div> 1028 1029 1030 1031 <div class="block chief"> 1032 <p class="blockTitle" id="pblkChief">ÐлавнÑй ÑедакÑоÑ</p> 1033 <a href="https://med-sovet.pro/jour/pages/view/chiefeditor" target="_blank" style="line-height:0; display:block; margin-bottom: 20px"> 1034 <img src="https://www.med-sovet.pro/public/journals/1/mobileEditorPhoto_ru_RU.jpg" /> 1035 </a> 1036 <a href="https://med-sovet.pro/jour/pages/view/chiefeditor" target="_blank" id="ablkChief"> 1037 ÐÑмÑÑ Ð°Ð¼ÐµÑов Ð.Ð. 1038 </a> 1039 </div> 1040 <div class="block flex" id="sidebarCrossref"> 1041 <a href="https://www.med-sovet.pro/jour/about/editorialPolicies#openAccessPolicy" title="ÐолиÑика Ñвободного доÑÑÑпа" target="_blank" rel="nofollow" class="flexNormal" id="crOA"> 1042 <img src="/assets/img/OAlogo.svg"> 1043 </a> 1044 <a class="flexNormal" title="СÑаÑÑи жÑÑнала в Crossref" target="_blank" rel="nofollow" href="http://search.crossref.org/?q=2079-701X" id="crCR"> 1045 <img src="/assets/img/bage_crossref.svg"> 1046 </a> 1047 <a class="flexNormal" href="https://www.med-sovet.pro/jour/about/editorialPolicies" target="_blank" rel="nofollow" id="crAP"><img src="/assets/img/icon_antiplagiat.svg"></a> 1048 <div class="noadv"> 1049 <a href="https://www.med-sovet.pro/jour/about/editorialPolicies">* не ÑвлÑеÑÑÑ Ñекламой</a> 1050 </div> 1051 </div> 1052 1053<div class="block custom"> 1054 <div style="background: #ffffff; border: 1px solid #bfe6e3; border-radius: 16px; padding: 20px; margin-bottom: 20px; font-family: Arial, Helvetica, sans-serif; color: #203233;"> 1055<div style="display: inline-block; font-size: 11px; font-weight: bold; text-transform: uppercase; letter-spacing: .04em; color: #009b97; background: #e8f7f5; padding: 6px 10px; border-radius: 999px; margin-bottom: 10px;">ÐедиÑинÑкий ÑовеÑ</div> 1056<div style="font-size: 20px; font-weight: bold; margin-bottom: 6px;">ÐодпиÑÑвайÑеÑÑ Ð½Ð° наÑ</div> 1057<div style="font-size: 14px; color: #486364; margin-bottom: 16px; line-height: 1.5;">ÐовоÑÑи и маÑеÑÐ¸Ð°Ð»Ñ Ð¶ÑÑнала в Ñдобном ÑоÑмаÑе</div> 1058<!-- VK --> <a style="display: flex; justify-content: space-between; align-items: center; padding: 12px 14px; margin-bottom: 10px; border-radius: 12px; text-decoration: none; font-weight: 600; color: #203233; background: #eef8f7; border: 1px solid #bfe6e3;" href="https://vk.com/med_sovetpro" target="_blank"> ÐÐонÑакÑе <span style="font-size: 13px; color: #009b97;">ÐодпиÑаÑÑÑÑ</span> </a> <!-- MAX --> <a style="display: flex; justify-content: space-between; align-items: center; padding: 12px 14px; border-radius: 12px; text-decoration: none; font-weight: 600; color: #203233; background: #eef8f7; border: 1px solid #bfe6e3;" href="https://max.ru/join/97X8pSCkWY3vUhgwRi7Q9lvaCnvP4OqF4kbzy7qPbyI" target="_blank"> MAX <span style="font-size: 13px; color: #009b97;">ÐÑиÑоединиÑÑÑÑ</span> </a></div> 1059</div> <div class="block custom"> 1060 <p class="x_MsoNormal" style="text-align: center;"><strong>Ðо ÑекомендаÑии ÐÑезидиÑма ÐÐÐ Ð¾Ñ 8 декабÑÑ 2023 г. â 31/1-Ñазн</strong></p> 1061<p class="x_MsoNormal" style="text-align: center;">"РкаÑегоÑиÑовании пеÑеÑÐ½Ñ ÑеÑензиÑÑемÑÑ Ð½Ð°ÑÑнÑÑ Ð¸Ð·Ð´Ð°Ð½Ð¸Ð¹, в коÑоÑÑÑ Ð´Ð¾Ð»Ð¶Ð½Ñ Ð±ÑÑÑ Ð¾Ð¿ÑÐ±Ð»Ð¸ÐºÐ¾Ð²Ð°Ð½Ñ Ð¾ÑновнÑе наÑÑнÑе ÑезÑлÑÑаÑÑ Ð´Ð¸ÑÑеÑÑаÑий на ÑоиÑкание ÑÑеной ÑÑепени кандидаÑа наÑк, на ÑоиÑкание ÑÑеной ÑÑепени докÑоÑа наÑк" жÑÑÐ½Ð°Ð»Ñ «ÐедиÑинÑкий Ñовеѻ пÑиÑвоена каÑегоÑÐ¸Ñ Ð1</p> 1062</div> 1063 <div class="block popular">
1064 <span class="blockTitle">ÐопÑлÑÑнÑе ÑÑаÑÑи</span> 1065 1066 <div class="inner" id="sidebar-popular" > 1067 <div class="pop"> 1068 1069 <div class="title"><a href="https://www.med-sovet.pro/jour/article/view/8152"> 1070 ÐÑÑекÑивноÑÑÑ Ð¸Ð¼Ð¼ÑнокоÑÑигиÑÑÑÑей ÑеÑапии ÑаÑÑо болеÑÑÐ¸Ñ Ð´ÐµÑей 1071 </a></div> 1072 <span class="issue">â 7 (2024)</span> 1073 </div> 1074 <div class="separator"></div> 1075 <div class="pop"> 1076 1077 <div class="title"><a href="https://www.med-sovet.pro/jour/article/view/6446"> 1078 ÐилиаÑнÑй конÑинÑÑм: акÑÑалÑнÑй взглÑд на Ð·Ð°Ð±Ð¾Ð»ÐµÐ²Ð°Ð½Ð¸Ñ Ð¶ÐµÐ»ÑевÑводÑÑÐ¸Ñ Ð¿ÑÑей 1079 </a></div> 1080 <span class="issue">â 15 (2021)</span> 1081 </div> 1082 <div class="separator"></div> 1083 <div class="pop"> 1084 1085 <div class="title"><a href="https://www.med-sovet.pro/jour/article/view/7328"> 1086 ÐиоÑимилÑÑ Ð°Ð½Ð°Ð»Ð¾Ð³Ð° инÑÑлина глаÑгин: Ð´Ð¾ÐºÐ°Ð·Ð°Ð½Ð½Ð°Ñ Ð±ÐµÐ·Ð¾Ð¿Ð°ÑноÑÑÑ, ÑÑÑекÑивноÑÑÑ, взаимозаменÑемоÑÑÑ 1087 </a></div> 1088 <span class="issue">â 23 (2022)</span> 1089 </div> 1090 <div class="separator"></div> 1091 <div class="pop"> 1092 1093 <div class="title"><a href="https://www.med-sovet.pro/jour/article/view/6277"> 1094 ÐÑименение ÐºÐ¾Ð»Ñ Ð¸Ñина пÑи подагÑе 1095 </a></div> 1096 <span class="issue">â 10 (2021)</span> 1097 </div> 1098 <div class="separator"></div> 1099 <div class="pop"> 1100 1101 <div class="title"><a href="https://www.med-sovet.pro/jour/article/view/7615"> 1102 ÐÑÑеоÑаÑÐºÐ¾Ð¿ÐµÐ½Ð¸Ñ ÐºÐ°Ðº ÑпÑÑник ÑÑаÑÐµÐ½Ð¸Ñ 1103 </a></div> 1104 <span class="issue">â 9 (2023)</span> 1105 </div> 1106 <div class="separator"></div> 1107 <div class="pop"> 1108 1109 <div class="title"><a href="https://www.med-sovet.pro/jour/article/view/9102"> 1110 ТопиÑеÑкие бакÑеÑиалÑнÑе лизаÑÑ Ð² ÑеÑапии паÑиенÑов Ñ Ð¸Ð½ÑекÑионно-воÑпалиÑелÑнÑми заболеваниÑми лоÑ-оÑганов 1111 </a></div> 1112 <span class="issue">â 7 (2025)</span> 1113 </div> 1114 <div class="separator"></div> 1115 </div> 1116 </div> 1117<div class="block custom"> 1118 <p>.</p> 1119</div> <div class="block custom"> 1120 <div style="max-width: 760px; margin: 0 auto; padding: 12px 14px; border: 1px solid #e7e7e7; border-radius: 10px; background: #fff;"> 1121<div style="font-size: 16px; font-weight: bold; text-align: center; margin: 0 0 10px;">ÐодпиÑÑвайÑеÑÑ Ð½Ð° «ÐедиÑинÑкий Ñовеѻ</div> 1122<div style="display: flex; gap: 8px; flex-wrap: nowrap; justify-content: space-between;"><a style="flex: 1; display: flex; align-items: center; justify-content: center; gap: 8px; padding: 8px 10px; border-radius: 999px; text-decoration: none; font-weight: 600; color: #111; border: 1px solid #eaeaea; background: #f7f7f7;" href="https://vk.com/med_sovetpro" rel="noopener noreferrer" target="_blank"> <span style="display: inline-flex; align-items: center; justify-content: center; width: 22px; height: 22px; border-radius: 50%; background: #2787F5; color: #fff; font-size: 11px; font-weight: 800; line-height: 1;">VK</span> <span style="font-size: 13px;">ÐÐ</span> </a> <a style="flex: 1; display: flex; align-items: center; justify-content: center; gap: 8px; padding: 8px 10px; border-radius: 999px; text-decoration: none; font-weight: 600; color: #111; border: 1px solid #eaeaea; background: #f7f7f7;" href="https://ok.ru/remedium" rel="noopener noreferrer" target="_blank"> <span style="display: inline-flex; align-items: center; justify-content: center; width: 22px; height: 22px; border-radius: 50%; background: #F58220; color: #fff; font-size: 11px; font-weight: 800; line-height: 1;">OK</span> <span style="font-size: 13px;">ÐÐ</span> </a> <a style="flex: 1; display: flex; align-items: center; justify-content: center; gap: 8px; padding: 8px 10px; border-radius: 999px; text-decoration: none; font-weight: 600; color: #111; border: 1px solid #eaeaea; background: #f7f7f7;" href="https://max.ru/join/97X8pSCkWY3vUhgwRi7Q9lvaCnvP4OqF4kbzy7qPbyI" rel="noopener noreferrer" target="_blank"> <span style="display: inline-flex; align-items: center; justify-content: center; width: 22px; height: 22px; border-radius: 50%; background: #111; color: #fff; font-size: 10px; font-weight: 900; line-height: 1;">MAX</span> <span style="font-size: 13px;">Max</span> </a></div> 1123<div style="font-size: 12px; color: #777; text-align: center; margin-top: 8px; line-height: 1.2;">ÐодпиÑка оÑкÑÑваеÑÑÑ Ð² новом окне</div> 1124</div> 1125</div> 1126 <div class="block banners">
1127 <span class="blockTitle">ÐндекÑаÑÐ¸Ñ Ð¶ÑÑнала</span> 1128 <a href="https://www.scopus.com/sourceid/21101037906" target="_blank" rel="nofollow" order="1"><img src="//cdn.elpub.ru/assets/img/banners/Scopus_120x33.jpg"></a> 1129 <a href="https://doaj.org/toc/2658-5790" target="_blank" rel="nofollow" order="2"><img src="//cdn.elpub.ru/assets/img/banners/doaj_logo.jpg"></a> 1130 <a href="https://www.clarivate.ru/products/web-of-science-rsci" target="_blank" rel="nofollow" order="3"><img src="//cdn.elpub.ru/assets/img/banners/RSCI.jpg"></a> 1131 <a href="https://vak.minobrnauki.gov.ru/main" target="_blank" rel="nofollow" order="4"><img src="//cdn.elpub.ru/assets/img/banners/vak_t.jpg"></a> 1132 <a href="https://app.dimensions.ai/discover/publication?and_facet_journal=jour.1063449" target="_blank" rel="nofollow" order="5"><img src="//cdn.elpub.ru/assets/img/banners/Dimensions-395.jpg"></a> 1133 <a href="http://www.academickeys.com/all/choose_discipline.php?go=academicresources" target="_blank" rel="nofollow" order="6"><img src="//cdn.elpub.ru/assets/img/banners/academickeys.jpg"></a> 1134 <a href="https://elibrary.ru/title_about.asp?id=30962" target="_blank" rel="nofollow" order="7"><img src="//cdn.elpub.ru/assets/img/banners/elibrary.jpg"></a> 1135 <a href="http://www.openarchives.org/" target="_blank" rel="nofollow" order="8"><img src="//cdn.elpub.ru/assets/img/banners/OpenArchive.png"></a> 1136 <a href="http://aleph.rsl.ru/F/JB1S59NA31KABHIV8KUB82PJHS93A9MP8GIAVB2M2MFVNXFLAC-00338?&func=item-global&doc_library=RSL01&doc_number=003540042&year=&volume=&sub_library=" target="_blank" rel="nofollow" order="9"><img src="//cdn.elpub.ru/assets/img/banners/rgb140.jpg"></a> 1137 <a href="https://elibrary.ru/title_profile.asp?id=30962" target="_blank" rel="nofollow" order="10"><img src="//cdn.elpub.ru/assets/img/banners/rinc140.jpg"></a> 1138 <a href="https://socionet.ru/collection.xml?h=spz:neicon" target="_blank" rel="nofollow" order="11"><img src="//cdn.elpub.ru/assets/img/banners/socionet.jpg"></a> 1139 <a href="http://ulrichsweb.serialssolutions.com/search/820308717" target="_blank" rel="nofollow" order="12"><img src="//cdn.elpub.ru/assets/img/banners/ulrich_t.jpg"></a> 1140 <a href="http://hinari.summon.serialssolutions.com/#!/search?ho=f&l=en&q=2079-701X" target="_blank" rel="nofollow" order="13"><img src="//cdn.elpub.ru/assets/img/banners/R4L_120x33.png"></a> 1141 <a href="https://www.lens.org/lens/scholar/search/results?q=source.issn:2079701x&toYear=2019&fromYear=1950&dateFilterField=year_published&filterMap=%7B%7D&preview=true" target="_blank" rel="nofollow" order="14"><img src="//cdn.elpub.ru/assets/img/banners/lens_120x33.png"></a> 1142 <a href="https://www.worldcat.org/search?q=2079-701X" target="_blank" rel="nofollow" order="15"><img src="//cdn.elpub.ru/assets/img/banners/worldcat.jpg"></a> 1143 <a href="https://cyberleninka.ru/journal/n/meditsinskiy-sovet?i=1044214" target="_blank" rel="nofollow" order="16"><img src="//cdn.elpub.ru/assets/img/banners/cyberleninka120x33.jpg"></a> 1144 <a href="https://portal.issn.org/resource/ISSN/2658-5790" target="_blank" rel="nofollow" order="17"><img src="//cdn.elpub.ru/assets/img/banners/road-issn_0.png"></a> 1145 <a href="https://scholar.google.ru/scholar?hl=ru&as_sdt=0%2C5&q=2079-701X&btnG=" target="_blank" rel="nofollow" order="18"><img src="//cdn.elpub.ru/assets/img/banners/googlescholar.jpg"></a> 1146 <a href="http://www.iprbookshop.ru/366.html" target="_blank" rel="nofollow" order="19"><img src="//cdn.elpub.ru/assets/img/banners/iprbooks.jpg"></a> 1147 <a href="https://www.mendeley.com/search/?page=1&query=2079-701X&sortBy=relevance" target="_blank" rel="nofollow" order="20"><img src="//cdn.elpub.ru/assets/img/banners/Mendeley.jpg"></a> 1148 <a href="https://miar.ub.edu/issn/2079-701X" target="_blank" rel="nofollow" order="21"><img src="//cdn.elpub.ru/assets/img/banners/miar120x33.jpg"></a> 1149 <a href="http://opencitations.net/" target="_blank" rel="nofollow" order="22"><img src="//cdn.elpub.ru/assets/img/banners/openc120x33.jpg"></a> 1150 <a href="https://unpaywall.org/sources" target="_blank" rel="nofollow" order="23"><img src="//cdn.elpub.ru/assets/img/banners/unpaywall120x33.jpg"></a> 1151 <a href="https://xueshu.baidu.com/s?wd=2079-701X&tn=SE_baiduxueshu_c1gjeupa&cl=3&ie=utf-8&bs=1998-5746&f=8&rsv_bp=1&rsv_sug2=1&sc_f_para=sc_tasktype%3D%7BfirstSimpleSearch%7D&rsv_spt=3&rsv_n=2" target="_blank" rel="nofollow" order="24"><img src="//cdn.elpub.ru/assets/img/banners/xueshu120x33.jpg"></a> 1152 <a href="https://enscholar.cnki.net/journal/index/dd843644-e1ec-4d1b-b9d3-9c3d0c763645" target="_blank" rel="nofollow" order="25"><img src="//cdn.elpub.ru/assets/img/banners/cnki.png"></a> 1153 <a href="https://openalex.org/sources/V4210203888" target="_blank" rel="nofollow" order="26"><img src="//cdn.elpub.ru/assets/img/banners/openalex_120x33.jpg"></a> 1154 <a href="https://www.scilit.net/journal/3609296" target="_blank" rel="nofollow" order="27"><img src="//cdn.elpub.ru/assets/img/banners/Scilit_120x33.png"></a> 1155 <a href="https://www.wikidata.org/wiki/Q96729160" target="_blank" rel="nofollow" order="28"><img src="//cdn.elpub.ru/assets/img/banners/wikidatawiki_120x33.jpg"></a> 1156 <a href="https://na.neicon.ru/" target="_blank" rel="nofollow" order="29"><img src="//cdn.elpub.ru/assets/img/banners/neuroass120x33.jpg"></a> 1157 <a href="https://scholar.archive.org/search?q=%222079-701X%22" target="_blank" rel="nofollow" order="30"><img src="//cdn.elpub.ru/assets/img/banners/internetArchive.jpg"></a> 1158 <a href="https://keepers.issn.org/" target="_blank" rel="nofollow" order="31"><img src="//cdn.elpub.ru/assets/img/banners/Keepers_120x33.jpg"></a> 1159 <a href="https://medj.rucml.ru/" target="_blank" rel="nofollow" order="32"><img src="//cdn.elpub.ru/assets/img/banners/rusmed_s_ramkoi.png"></a> 1160 <a href="https://journalrank.rcsi.science/ru/record-sources/details/26797" target="_blank" rel="nofollow" order="33"><img src="//cdn.elpub.ru/assets/img/banners/belyi_spisok_banner120x33.png"></a> 1161 <div class="noadv"> 1162 <a href="https://www.med-sovet.pro/jour/about/editorialPolicies">
1162* не ÑвлÑеÑÑÑ Ñекламой</a> 1163 </div> 1164 </div> 1165 1166 1167<div class="block" id="sidebarRTArticleTools"> 1168 1169 <span class="blockTitle">ÐнÑÑÑÑменÑÑ ÑÑаÑÑи</span> 1170 <div class="articleToolItem"> 1171 <img src="https://www.med-sovet.pro/plugins/blocks/readingTools/icons/findingReferences.png" class="articleToolIcon" /> <a href="javascript:openRTWindow('https://www.med-sovet.pro/jour/rt/findingReferences/10423/0');">ÐоиÑк ÑÑÑлок</a> 1172 </div> 1173 <div class="articleToolItem"> 1174 <img src="https://www.med-sovet.pro/plugins/blocks/readingTools/icons/emailArticle.png" class="articleToolIcon" /> 1175 ÐоÑлаÑÑ ÑÑаÑÑÑ Ð¿Ð¾ Ñл. поÑÑе <span style="font-size: 0.8em">(ÐÐµÐ¾Ð±Ñ Ð¾Ð´Ð¸Ð¼Ð¾ Ð¸Ð¼Ñ Ð¿Ð¾Ð»ÑзоваÑÐµÐ»Ñ (логин))</span> </div> 1176 <div class="articleToolItem"> 1177 <img src="https://www.med-sovet.pro/plugins/blocks/readingTools/icons/emailArticle.png" class="articleToolIcon" /> 1178 СвÑзаÑÑÑÑ Ñ Ð°Ð²ÑоÑом <span style="font-size: 0.8em">(ÐÐµÐ¾Ð±Ñ Ð¾Ð´Ð¸Ð¼Ð¾ Ð¸Ð¼Ñ Ð¿Ð¾Ð»ÑзоваÑÐµÐ»Ñ (логин))</span> </div> 1179 </div> 1180<div class="block" id="sidebarRTAuthorBios"> 1181 <span class="blockTitle"> 1182 Ðб авÑоÑÐ°Ñ 1183 </span> 1184 <div id="authorBio"> 1185 <p> 1186 <em>Ð. Ð. Ð¡Ð°Ñ Ð½Ð¾Ð²Ð°</em><br /> 1187 РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; 1188ÐÐР«СкандинавÑкий ЦенÑÑ ÐдоÑовÑÑ» <br/>РоÑÑÐ¸Ñ </p> 1189 1190 <p><p><strong>Ð¡Ð°Ñ Ð½Ð¾Ð²Ð° ÐкаÑеÑина ÐвгенÑевна, </strong>ÑоиÑкаÑÐµÐ»Ñ ÐºÐ°ÑедÑÑ ÑеÑапии и полимоÑбидной паÑологии имени академика Ð.С. ÐовÑи, РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; вÑаÑÑндокÑинолог, ÐÐР«СкандинавÑкий ЦенÑÑ ÐдоÑовÑÑ»</p><p><em>125993, ÐоÑква, Ñл. ÐаÑÑикаднаÑ, д. 2/1, ÑÑÑ. 1,</em></p><p><em>111024, ÐоÑква, Ñл. 2-Ñ ÐабелÑнаÑ, д. 2, ÑÑÑ. 25, 26, 37</em></p><p> </p></p> 1191 </div> 1192 <div class="separator"></div> 1193 <div id="authorBio"> 1194 <p> 1195 <em>Ð. Ð. ÐавÑилова</em><br /> 1196 РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; 1197ÐÐР«СкандинавÑкий ЦенÑÑ ÐдоÑовÑÑ» <br/>РоÑÑÐ¸Ñ </p> 1198 1199 <p><p><strong>ÐавÑилова ÐаÑалÑÑ ÐвгенÑевна, </strong>д.м.н., пÑоÑеÑÑÐ¾Ñ ÐºÐ°ÑедÑÑ ÑеÑапии и полимоÑбидной паÑологии имени академика Ð.С. ÐовÑи, РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; генеÑалÑнÑй диÑекÑоÑ, главнÑй вÑаÑ, ÐÐР«СкандинавÑкий ЦенÑÑ ÐдоÑовÑÑ»</p><p><em>125993, ÐоÑква, Ñл. ÐаÑÑикаднаÑ, д. 2/1, ÑÑÑ. 1,</em></p><p><em>111024, ÐоÑква, Ñл. 2-Ñ ÐабелÑнаÑ, д. 2, ÑÑÑ. 25, 26, 37</em></p><p> </p></p> 1200 </div> 1201 <div class="separator"></div> 1202 <div id="authorBio"> 1203 <p> 1204 <em>Ð. Ð. ÐÑÑÑоÑмова</em><br /> 1205 РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; 1206ÐеÑвÑй ÐоÑковÑкий гоÑÑдаÑÑÑвеннÑй медиÑинÑкий ÑнивеÑÑиÑÐµÑ Ð¸Ð¼ÐµÐ½Ð¸ Ð.Ð. СеÑенова (СеÑеновÑкий УнивеÑÑиÑеÑ) <br/>РоÑÑÐ¸Ñ </p> 1207 1208 <p><p><strong>ÐÑÑÑоÑмова</strong><strong> </strong><strong>ÐлÑга</strong><strong> </strong><strong>ÐмиÑÑиевна,</strong><strong> </strong>д.м.н., пÑоÑеÑÑоÑ, заведÑÑÑÐ°Ñ ÐºÐ°ÑедÑой ÑеÑапии и полимоÑбидной паÑологии имени академика Ð.С. ÐовÑи, РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; пÑоÑеÑÑÐ¾Ñ ÐºÐ°ÑедÑÑ ÐºÐ»Ð¸Ð½Ð¸ÑеÑкой ÑаÑмакологии и пÑопедевÑики внÑÑÑÐµÐ½Ð½Ð¸Ñ Ð±Ð¾Ð»ÐµÐ·Ð½ÐµÐ¹, ÐеÑвÑй ÐоÑковÑкий гоÑÑдаÑÑÑвеннÑй медиÑинÑкий ÑнивеÑÑиÑÐµÑ Ð¸Ð¼ÐµÐ½Ð¸ Ð.Ð. СеÑенова (СеÑеновÑкий УнивеÑÑиÑеÑ);</p><p><em>125993, ÐоÑква, Ñл. ÐаÑÑикаднаÑ, д. 2/1, ÑÑÑ. 1,</em></p><p>119048, ÐоÑква, Ñл. ТÑÑбеÑкаÑ, д. 8, ÑÑÑ. 2</p></p> 1209 </div> 1210 <div class="separator"></div> 1211 <div id="authorBio"> 1212 <p> 1213 <em>Ð. Ð. ÐоÑеÑков</em><br /> 1214 РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑÐ°Ð·Ð¾Ð²Ð°Ð½Ð¸Ñ <br/>РоÑÑÐ¸Ñ </p> 1215 1216 <p><p><strong>ÐоÑеÑков ÐлекÑей ÐвановиÑ, </strong>к.м.н., доÑенÑ, доÑÐµÐ½Ñ ÐºÐ°ÑедÑÑ ÑеÑапии и полимоÑбидной паÑологии имени академика Ð.С. ÐовÑи</p><p><em>125993, ÐоÑква, Ñл. ÐаÑÑикаднаÑ, д. 2/1, ÑÑÑ. 1</em></p><p> </p></p> 1217 </div> 1218 <div class="separator"></div> 1219 <div id="authorBio"> 1220 <p> 1221 <em>С. С. Телкова</em><br /> 1222 РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑÐ°Ð·Ð¾Ð²Ð°Ð½Ð¸Ñ <br/>РоÑÑÐ¸Ñ </p> 1223 1224 <p><p><strong>Телкова СвеÑлана СеÑгеевна, </strong>аÑÑиÑÑенÑ, ÑÑаÑÑий лабоÑанÑ, аÑпиÑÐ°Ð½Ñ ÐºÐ°ÑедÑÑ ÑеÑапии и полимоÑбидной паÑологии имени академика Ð.С. ÐовÑи</p><p><em>125993, ÐоÑква, Ñл. ÐаÑÑикаднаÑ, д. 2/1, ÑÑÑ. 1</em></p></p> 1225 </div> 1226 <div class="separator"></div> 1227 <div id="authorBio"> 1228 <p> 1229 <em>Ю. С. ÐоÑÑкова</em><br /> 1230 РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; 1231ÐÐР«СкандинавÑкий ЦенÑÑ ÐдоÑовÑÑ» <br/>РоÑÑÐ¸Ñ </p> 1232 1233 <p><p><strong>ÐоÑÑкова</strong><strong> </strong><strong>Ð®Ð»Ð¸Ñ Ð¡ÑаниÑлавовна, </strong>ÑоиÑкаÑÐµÐ»Ñ ÐºÐ°ÑедÑÑ ÑеÑапии и полимоÑбидной паÑологии имени академика Ð.С. ÐовÑи, РоÑÑийÑÐºÐ°Ñ Ð¼ÐµÐ´Ð¸ÑинÑÐºÐ°Ñ Ð°ÐºÐ°Ð´ÐµÐ¼Ð¸Ñ Ð½ÐµÐ¿ÑеÑÑвного пÑоÑеÑÑионалÑного обÑазованиÑ; вÑаÑ-каÑдиолог, ÐÐР«СкандинавÑкий ЦенÑÑ ÐдоÑовÑÑ»</p><p><em>125993, ÐоÑква, Ñл. ÐаÑÑикаднаÑ, д. 2/1, ÑÑÑ. 1,</em></p><p><em>
1233111024, ÐоÑква, Ñл. 2-Ñ ÐабелÑнаÑ, д. 2, ÑÑÑ. 25, 26, 37</em></p></p> 1234 </div> 1235 1236 </div> 1237<div class="block" id="sidebarKeywordCloud"> 1238 <span class="blockTitle">Ðблако Ñегов</span> 1239 1240 <a href='https://www.med-sovet.pro/jour/search?subject="COVID-19"'><span style="font-size: 94.654088050314%;">COVID-19</span></a> 1241 1242 <a href='https://www.med-sovet.pro/jour/search?subject="children"'><span style="font-size: 92.295597484277%;">children</span></a> 1243 1244 <a href='https://www.med-sovet.pro/jour/search?subject="аллеÑгиÑеÑкий ÑиниÑ"'><span style="font-size: 88.679245283019%;">аллеÑгиÑеÑкий ÑиниÑ</span></a> 1245 1246 <a href='https://www.med-sovet.pro/jour/search?subject="анÑибакÑеÑиалÑÐ½Ð°Ñ ÑеÑапиÑ"'><span style="font-size: 87.106918238994%;">анÑибакÑеÑиалÑÐ½Ð°Ñ ÑеÑапиÑ</span></a> 1247 1248 <a href='https://www.med-sovet.pro/jour/search?subject="аÑÑеÑиалÑÐ½Ð°Ñ Ð³Ð¸Ð¿ÐµÑÑензиÑ"'><span style="font-size: 88.679245283019%;">аÑÑеÑиалÑÐ½Ð°Ñ Ð³Ð¸Ð¿ÐµÑÑензиÑ</span></a> 1249 1250 <a href='https://www.med-sovet.pro/jour/search?subject="аÑопиÑеÑкий деÑмаÑиÑ"'><span style="font-size: 86.949685534591%;">аÑопиÑеÑкий деÑмаÑиÑ</span></a> 1251 1252 <a href='https://www.med-sovet.pro/jour/search?subject="беÑеменноÑÑÑ"'><span style="font-size: 97.48427672956%;">беÑеменноÑÑÑ</span></a> 1253 1254 <a href='https://www.med-sovet.pro/jour/search?subject="бÑÐ¾Ð½Ñ Ð¸Ð°Ð»ÑÐ½Ð°Ñ Ð°ÑÑма"'><span style="font-size: 92.138364779874%;">бÑÐ¾Ð½Ñ Ð¸Ð°Ð»ÑÐ½Ð°Ñ Ð°ÑÑма</span></a> 1255 1256 <a href='https://www.med-sovet.pro/jour/search?subject="деÑи"'><span style="font-size: 174.8427672956%;">деÑи</span></a> 1257 1258 <a href='https://www.med-sovet.pro/jour/search?subject="диагноÑÑика"'><span style="font-size: 102.51572327044%;">диагноÑÑика</span></a> 1259 1260 <a href='https://www.med-sovet.pro/jour/search?subject="каÑеÑÑво жизни"'><span style="font-size: 88.207547169811%;">каÑеÑÑво жизни</span></a> 1261 1262 <a href='https://www.med-sovet.pro/jour/search?subject="каÑелÑ"'><span style="font-size: 89.150943396226%;">каÑелÑ</span></a> 1263 1264 <a href='https://www.med-sovet.pro/jour/search?subject="леÑение"'><span style="font-size: 123.89937106918%;">леÑение</span></a> 1265 1266 <a href='https://www.med-sovet.pro/jour/search?subject="ожиÑение"'><span style="font-size: 95.911949685535%;">ожиÑение</span></a> 1267 1268 <a href='https://www.med-sovet.pro/jour/search?subject="пÑобиоÑики"'><span style="font-size: 88.993710691824%;">пÑобиоÑики</span></a> 1269 1270 <a href='https://www.med-sovet.pro/jour/search?subject="пÑоÑилакÑика"'><span style="font-size: 96.698113207547%;">пÑоÑилакÑика</span></a> 1271 1272 <a href='https://www.med-sovet.pro/jour/search?subject="ÑÐ°Ñ Ð°ÑнÑй диабеÑ"'><span style="font-size: 101.57232704403%;">ÑÐ°Ñ Ð°ÑнÑй диабеÑ</span></a> 1273 1274 <a href='https://www.med-sovet.pro/jour/search?subject="ÑÐ°Ñ Ð°ÑнÑй Ð´Ð¸Ð°Ð±ÐµÑ 2-го Ñипа"'><span style="font-size: 92.138364779874%;">ÑÐ°Ñ Ð°ÑнÑй Ð´Ð¸Ð°Ð±ÐµÑ 2-го Ñипа</span></a> 1275 1276 <a href='https://www.med-sovet.pro/jour/search?subject="ÑеÑапиÑ"'><span style="font-size: 92.452830188679%;">ÑеÑапиÑ</span></a> 1277 1278 <a href='https://www.med-sovet.pro/jour/search?subject="ÑакÑоÑÑ ÑиÑка"'><span style="font-size: 88.050314465409%;">ÑакÑоÑÑ ÑиÑка</span></a> 1279 1280 <a href='https://www.med-sovet.pro/jour/search?subject="ÑÑÑекÑивноÑÑÑ"'><span style="font-size: 87.893081761006%;">ÑÑÑекÑивноÑÑÑ</span></a> 1281 </div> <div class="block" id="notification"> 1282 <span class="blockTitle">УведомлениÑ</span> 1283 <ul> 1284 <li><a href="https://www.med-sovet.pro/jour/notification">ÐоÑмоÑÑеÑÑ</a></li> 1285 <li><a href="https://www.med-sovet.pro/jour/notification/subscribeMailList">ÐодпиÑаÑÑÑÑ</a></li> 1286 </ul> 1287</div> 1288 1289 </div> 1290 1291 1292<div class="clear"></div> 1293</div> 1294</div> 1295<div class="clear"></div> 1296<div class="footer"> 1297 <div class="container flex"> 1298 <div class="left"> 1299 <p>ÐбÑеÑÑво Ñ Ð¾Ð³ÑаниÑенной оÑвеÑÑÑвенноÑÑÑÑ Â«ÐРУÐÐÐ Ð ÐÐÐÐÐУл<br />ÐдÑÐµÑ Ð¼ÐµÑÑÐ¾Ð½Ð°Ñ Ð¾Ð¶Ð´ÐµÐ½Ð¸Ñ: 105082, г. ÐоÑква, Ñл. ÐакÑнинÑкаÑ, д. 71<br />ÐÐÐ Ð: 1067746819470  ÐÐÐ: 7701669956<br />ÐонÑакÑнÑе даннÑе: ТелеÑон: +7 (495) 780-34-25  |  ÐлекÑÑÐ¾Ð½Ð½Ð°Ñ Ð¿Ð¾ÑÑа: [email protected]</p> 1300 <a class="footer-politics" href="https://www.med-sovet.pro/jour/about/privacyPolicy"> 1301 ÐбÑабоÑка пеÑÑоналÑнÑÑ Ð´Ð°Ð½Ð½ÑÑ 1302 </a> 1303 </div> 1304 <div class="right"> 1305 Ñоздано и поддеÑживаеÑÑÑ <a target="blank" href="http://neicon.ru">NEICON</a><br/>
1305(лабоÑаÑоÑÐ¸Ñ <a target="blank" href="http://elpub.ru">Elpub</a>) 1306 <a class="rss" href="https://www.med-sovet.pro/jour/gateway/plugin/WebFeedGatewayPlugin/rss"><img src="/assets/img/RSS.svg"></a> 1307 </div> 1308 </div> 1309</div> 1310<a id="totop"></a> 1311 1312 1313</div> 1314<div id="cookie-banner-wrapper" style="display: none;"> 1315 <div id="cookie-popup"> 1316 <center> 1317 <h4>ÐÑполÑзование кÑки-Ñайлов</h4> 1318 <a href="#" class="close-popup" onClick="return PopUp('hide')"></a> 1319 <p>ÐÐ»Ñ Ð¾Ð¿ÑималÑной ÑабоÑÑ ÑайÑа жÑÑнала и опÑимизаÑии его дизайна Ð¼Ñ Ð¸ÑполÑзÑем кÑки-ÑайлÑ, а Ñакже ÑеÑÐ²Ð¸Ñ Ð¯Ð½Ð´ÐµÐºÑ.ÐеÑÑика Ð´Ð»Ñ ÑбоÑа и ÑÑаÑиÑÑиÑеÑкого анализа даннÑÑ Ð¾ поÑеÑении Ðами ÑÑÑÐ°Ð½Ð¸Ñ ÑайÑа. ÐÑÐ¾Ð´Ð¾Ð»Ð¶Ð°Ñ Ð¸ÑполÑзоваÑÑ ÑайÑ, ÐÑ ÑоглаÑаеÑеÑÑ Ð½Ð° иÑполÑзование кÑки-Ñайлов и Ñказанного ÑеÑвиÑа.</p> 1320 </center> 1321 </div> 1322</div> 1323 1324 1325 1326
1327<script type="text/javascript" src="https://www.med-sovet.pro/assets/js/slick.min.js"></script>
vendor: 1 bytes, line 1327
1327
1328<script type="text/javascript" src="https://www.med-sovet.pro/assets/js/select2.min.js"></script>
vendor: 1 bytes, line 1328
1328
1329<script type="text/javascript" src="https://www.med-sovet.pro/assets/js/i18n/ru.js"></script>
vendor: 1 bytes, line 1329
1329
1330<script type="text/javascript" src="https://www.med-sovet.pro/assets/js/script.js?v=20260921182516"></script>
vendor: 1 bytes, line 1330
1330
1331<script type="text/javascript" src="https://www.med-sovet.pro/styles/style.js"></script>
vendor: 1 bytes, line 1331
1331
1332<script type="text/javascript" src="https://www.med-sovet.pro/assets/js/cookie-banner-popup.js"></script>
1332 1333 1334</body> 1335</html> 1336<!-- URL: https://www.med-sovet.pro -->
Line numbers count LF bytes from the start of the resource, as the search results do. Vendor segments are library code the classifier recognised; they are stored but not indexed. Bytes are shown as Latin1 characters, one per byte.